Physicians Realty Trust - Quarter Report: 2013 September (Form 10-Q)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2013
or
o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission file number: 001-36007
PHYSICIANS REALTY TRUST
(Exact Name of Registrant as Specified in its Charter)
Maryland (State of Organization) |
|
46-2519850 (IRS Employer Identification No.) |
|
|
|
250 East Wisconsin Avenue Suite 1900 Milwaukee, Wisconsin (Address of Principal Executive Offices) |
|
53202 (Zip Code) |
(414) 978-6494
(Registrants Telephone Number, Including Area Code)
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. x Yes o No
Indicate by check mark whether the Registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files). x Yes o No
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act. (Check one):
Large Accelerated Filer |
o |
|
Accelerated Filer |
o |
|
|
|
|
|
Non-Accelerated Filer |
x (Do not check if a smaller reporting company) |
|
Smaller reporting company |
o |
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). o Yes x No
The number of the Registrants common shares outstanding on November 8, 2013 was 12,003,597.
PHYSICIANS REALTY TRUST
Quarterly Report on Form 10-Q
for the Quarter Ended September 30, 2013
|
|
Page |
|
|
Number |
| ||
|
|
|
| ||
|
2 | |
|
3 | |
|
4 | |
|
5 | |
|
Notes to Unaudited Condensed Consolidated and Combined Financial Statements |
6 |
|
|
|
Managements Discussion and Analysis of Financial Condition and Results of Operation |
16 | |
30 | ||
30 | ||
|
|
|
| ||
31 | ||
31 | ||
31 | ||
32 | ||
32 | ||
32 | ||
33 | ||
|
|
|
35 |
Physicians Realty Trust and Predecessor
Condensed Consolidated and Combined Balance Sheets
(In thousands, except share and per share data)
|
|
|
|
Predecessor |
| ||
|
|
September 30, |
|
December 31, |
| ||
|
|
2013 |
|
2012 |
| ||
|
|
(unaudited) |
|
|
| ||
ASSETS |
|
|
|
|
| ||
Investment properties: |
|
|
|
|
| ||
Income producing real estate |
|
$ |
176,883 |
|
$ |
89,878 |
|
Tenant improvements |
|
5,193 |
|
5,132 |
| ||
Property under development |
|
225 |
|
675 |
| ||
Land |
|
23,914 |
|
15,464 |
| ||
|
|
206,215 |
|
111,149 |
| ||
Accumulated depreciation |
|
(18,903 |
) |
(16,495 |
) | ||
Total investment properties, net |
|
187,312 |
|
94,654 |
| ||
Cash and cash equivalents |
|
4,233 |
|
2,614 |
| ||
Tenant receivables, net |
|
710 |
|
682 |
| ||
Deferred costs, net |
|
2,012 |
|
1,107 |
| ||
Lease intangibles, net |
|
20,716 |
|
5,243 |
| ||
Other assets |
|
5,652 |
|
3,292 |
| ||
Total assets |
|
$ |
220,635 |
|
$ |
107,592 |
|
LIABILITIES AND EQUITY |
|
|
|
|
| ||
Liabilities: |
|
|
|
|
| ||
Accounts payable to related parties |
|
$ |
|
|
$ |
1,530 |
|
Accounts payable |
|
485 |
|
802 |
| ||
Dividends payable |
|
2,655 |
|
|
| ||
Accrued expenses and other liabilities |
|
2,329 |
|
1,031 |
| ||
Derivative liabilities |
|
437 |
|
643 |
| ||
Debt |
|
66,525 |
|
84,489 |
| ||
Total liabilities |
|
72,431 |
|
88,495 |
| ||
Equity: |
|
|
|
|
| ||
Common shares, $0.01 par value, 500,000,000 shares authorized, 12,003,597 shares issued and outstanding as of September 30, 2013 |
|
120 |
|
|
| ||
Additional paid-in capital |
|
122,980 |
|
|
| ||
Accumulated deficit |
|
(3,321 |
) |
|
| ||
Predecessor equity |
|
|
|
19,068 |
| ||
Total shareholders and Predecessor equity |
|
119,779 |
|
19,068 |
| ||
Noncontrolling interests |
|
28,425 |
|
29 |
| ||
Total equity |
|
148,204 |
|
19,097 |
| ||
Total liabilities and equity |
|
$ |
220,635 |
|
$ |
107,592 |
|
The accompanying notes are an integral part of these condensed consolidated and combined financial statements.
Physicians Realty Trust and Predecessor
Condensed Consolidated and Combined Statements of Operations
(Unaudited) (In thousands, except share and per share data)
|
|
Three Months Ended |
|
Nine Months Ended |
| ||||||||
|
|
September 30, |
|
September 30, |
| ||||||||
|
|
2013 |
|
Predecessor |
|
2013 |
|
Predecessor |
| ||||
Revenues: |
|
|
|
|
|
|
|
|
| ||||
Rental revenues |
|
$ |
2,920 |
|
$ |
2,359 |
|
$ |
7,952 |
|
$ |
7,396 |
|
Expense recoveries |
|
798 |
|
750 |
|
2,399 |
|
2,151 |
| ||||
Other revenues |
|
(5 |
) |
2 |
|
|
|
7 |
| ||||
Total revenues |
|
3,713 |
|
3,111 |
|
10,351 |
|
9,554 |
| ||||
Expenses: |
|
|
|
|
|
|
|
|
| ||||
Management fees |
|
|
|
238 |
|
475 |
|
713 |
| ||||
General and administrative |
|
1,285 |
|
104 |
|
1,507 |
|
292 |
| ||||
Operating expenses |
|
1,130 |
|
1,110 |
|
3,578 |
|
3,460 |
| ||||
Depreciation and amortization |
|
1,146 |
|
973 |
|
3,123 |
|
2,901 |
| ||||
Loss on sale of property under development |
|
2 |
|
161 |
|
2 |
|
228 |
| ||||
Acquisition expenses |
|
756 |
|
|
|
756 |
|
|
| ||||
Total expenses |
|
4,319 |
|
2,586 |
|
9,441 |
|
7,594 |
| ||||
Operating (loss)/income |
|
(606 |
) |
525 |
|
910 |
|
1,960 |
| ||||
Other expense/(income) |
|
|
|
|
|
|
|
|
| ||||
Interest expense |
|
826 |
|
1,203 |
|
3,114 |
|
3,667 |
| ||||
Change in fair value of derivatives, net |
|
(16 |
) |
|
|
(206 |
) |
(58 |
) | ||||
Net loss from continuing operations |
|
(1,416 |
) |
(678) |
|
(1,998 |
) |
(1,649 |
) | ||||
Discontinued Operations: |
|
|
|
|
|
|
|
|
| ||||
Loss from operations on discontinued investment properties |
|
|
|
(262 |
) |
|
|
(199 |
) | ||||
Gain on sale of investment properties |
|
|
|
1,179 |
|
|
|
1,519 |
| ||||
Income from discontinued operations |
|
|
|
917 |
|
|
|
1,320 |
| ||||
Net (loss)/income |
|
(1,416 |
) |
$ |
239 |
|
(1,998 |
) |
$ |
(329 |
) | ||
Less: Net (income)/ loss attributable to Predecessor |
|
(6 |
) |
|
|
576 |
|
|
| ||||
Less: Net loss attributable to noncontrolling interests |
|
262 |
|
|
|
262 |
|
|
| ||||
Net loss attributable to common shareholders |
|
$ |
(1,160 |
) |
|
|
$ |
(1,160 |
) |
|
| ||
Net loss per share: |
|
|
|
|
|
|
|
|
| ||||
Basic and diluted |
|
$ |
(0.10 |
) |
|
|
$ |
(0.10 |
) |
|
| ||
Weighted average common shares: |
|
|
|
|
|
|
|
|
| ||||
Basic and diluted |
|
11,486,011 |
|
|
|
11,486,011 |
|
|
| ||||
|
|
|
|
|
|
|
|
|
| ||||
Dividends/distributions declared per common share and unit |
|
$ |
0.18 |
|
|
|
$ |
0.18 |
|
|
|
The accompanying notes are an integral part of these condensed consolidated and combined financial statements.
Physicians Realty Trust and Predecessor
Condensed Consolidated and Combined Statement of Equity
(In thousands, except shares) (Unaudited)
|
|
Number of |
|
Par |
|
Additional |
|
Accumulated |
|
Predecessor |
|
Total |
|
Non- |
|
Total |
| |||||||
Predecessor Balance |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||
January 1, 2013 |
|
|
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
19,068 |
|
$ |
19,068 |
|
$ |
29 |
|
$ |
19,097 |
|
Net (loss)/income |
|
|
|
|
|
|
|
|
|
(712 |
) |
(712 |
) |
136 |
|
(576 |
) | |||||||
Transfer |
|
|
|
|
|
|
|
|
|
36 |
|
36 |
|
(36 |
) |
|
| |||||||
Distributions |
|
|
|
|
|
|
|
|
|
(211 |
) |
(211 |
) |
(209 |
) |
(420 |
) | |||||||
Balance July 24, 2013 |
|
|
|
|
|
|
|
|
|
18,181 |
|
18,181 |
|
(80 |
) |
18,101 |
| |||||||
Physicians Realty Trust |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||
Net proceeds from sale of common shares |
|
11,753,597 |
|
118 |
|
122,755 |
|
|
|
|
|
122,873 |
|
|
|
122,873 |
| |||||||
Formation Transactions |
|
|
|
|
|
36 |
|
|
|
(18,181 |
) |
(18,145 |
) |
17,791 |
|
(354 |
) | |||||||
Restricted share award grants |
|
250,000 |
|
2 |
|
189 |
|
|
|
|
|
191 |
|
|
|
191 |
| |||||||
Dividends declared |
|
|
|
|
|
|
|
(2,161 |
) |
|
|
(2,161 |
) |
(494 |
) |
(2,655 |
) | |||||||
Contributions |
|
|
|
|
|
|
|
|
|
|
|
|
|
11,535 |
|
11,535 |
| |||||||
Distributions |
|
|
|
|
|
|
|
|
|
|
|
|
|
(65 |
) |
(65 |
) | |||||||
Net loss |
|
|
|
|
|
|
|
(1,160 |
) |
|
|
(1,160 |
) |
(262 |
) |
(1,422 |
) | |||||||
Balance September 30, 2013 |
|
12,003,597 |
|
$ |
120 |
|
$ |
122,980 |
|
$ |
(3,321 |
) |
$ |
|
|
$ |
119,779 |
|
$ |
28,425 |
|
$ |
148,204 |
|
The accompanying notes are an integral part of these condensed consolidated and combined financial statements.
Physicians Realty Trust and Predecessor
Condensed Consolidated and Combined Statements of Cash Flows
(In thousands) (Unaudited)
|
|
Nine Months Ended |
| ||||
|
|
September 30, |
| ||||
|
|
2013 |
|
Predecessor |
| ||
Cash Flows from Operating Activities: |
|
|
|
|
| ||
Net loss |
|
$ |
(1,998 |
) |
$ |
(329 |
) |
Adjustments to reconcile net loss to net cash provided by operating activities |
|
|
|
|
| ||
Depreciation and amortization |
|
3,262 |
|
3,420 |
| ||
Gain on sale of investment properties |
|
|
|
(1,519 |
) | ||
Loss on sale of property under development |
|
2 |
|
228 |
| ||
Amortization of lease inducement and above market leases |
|
70 |
|
53 |
| ||
Change in fair value of derivatives, net |
|
(206 |
) |
(58 |
) | ||
Provision for bad debts |
|
36 |
|
123 |
| ||
Non-cash compensation |
|
191 |
|
|
| ||
Accelerated amortization of deferred financing costs |
|
94 |
|
|
| ||
(Increase) decrease in |
|
|
|
|
| ||
Tenant receivables |
|
(64 |
) |
330 |
| ||
Deferred costs |
|
(163 |
) |
(99 |
) | ||
Other assets |
|
(873 |
) |
(380 |
) | ||
Increase (decrease) in |
|
|
|
|
| ||
Accounts payable to related parties |
|
(1,530 |
) |
153 |
| ||
Accounts payable |
|
(316 |
) |
18 |
| ||
Accrued expenses and other liabilities |
|
1,298 |
|
484 |
| ||
Total Adjustments |
|
1,801 |
|
2,753 |
| ||
Net cash (used by)/provided by operating activities |
|
(197 |
) |
2,424 |
| ||
Cash Flows from Investing Activities: |
|
|
|
|
| ||
Proceeds from sale of investment properties |
|
448 |
|
14,525 |
| ||
Capital expenditures for acquisition of investment properties |
|
(100,084 |
) |
(30 |
) | ||
Lease inducement |
|
(1,543 |
) |
(618 |
) | ||
Net cash (used in)/provided by investing activities |
|
(101,179 |
) |
13,877 |
| ||
Cash Flows from Financing Activities: |
|
|
|
|
| ||
Proceeds from sale of common shares |
|
135,166 |
|
|
| ||
Offering costs |
|
(12,293 |
) |
|
| ||
Formation transactions |
|
(354 |
) |
|
| ||
Proceeds from credit facility borrowings |
|
19,850 |
|
|
| ||
Proceeds from issuance of debt |
|
163 |
|
|
| ||
Debt issuance costs |
|
(1,074 |
) |
(36 |
) | ||
Payments on notes payable |
|
(37,978 |
) |
(12,717 |
) | ||
Distributions to members and partners |
|
(211 |
) |
(708 |
) | ||
Contributions to noncontrolling interest |
|
|
|
309 |
| ||
Distributions to noncontrolling interest |
|
(274 |
) |
(478 |
) | ||
Net cash provided by/(used in) financing activities |
|
102,995 |
|
(13,630 |
) | ||
Net increase in cash and cash equivalents |
|
1,619 |
|
2,671 |
| ||
Cash and cash equivalents, beginning of year |
|
2,614 |
|
1,932 |
| ||
Cash and cash equivalents, end of period |
|
$ |
4,233 |
|
$ |
4,603 |
|
|
|
|
|
|
|
|
|
Supplemental disclosure of cash flow information interest paid during the year |
|
$ |
2,967 |
|
$ |
3,495 |
|
Supplemental disclosure of noncash activity-accrued dividends payable |
|
$ |
2,655 |
|
$ |
|
|
Supplemental disclosure of noncash activity-contributions to noncontrolling interest |
|
$ |
11,535 |
|
$ |
|
|
The accompanying notes are an integral part of these condensed consolidated and combined financial statements.
Physicians Realty Trust and Predecessor
Notes to Condensed Consolidated and Combined Financial Statements
Note 1Organization and Business
Physicians Realty Trust (the Trust) was organized in the state of Maryland on April 9, 2013. As of September 30, 2013, the Trust was authorized to issue up to 500,000,000 common shares of beneficial interest, par value $0.01 per share. The Trust filed a Registration Statement on Form S-11 with the Securities and Exchange Commission with respect to a proposed underwritten initial public offering (the IPO) and completed the IPO of its common shares and commenced operations on July 24, 2013.
Prior to completion of the IPO, the Trust elected to be taxed as a pass-through entity under subchapter S of the Internal Revenue Code of 1986. Effective upon completion of the IPO, the Trust revoked the subchapter S election. The Trust intends to elect to be taxed as a real estate investment trust (REIT) for federal income tax purposes commencing with a short taxable year beginning on the date of the revocation of the subchapter S election and ending on December 31, 2013. The Trust had no taxable income prior to electing REIT status. To qualify as a REIT, the Trust must meet certain organizational and operational requirements, including a requirement to distribute at least 90% of its annual REIT taxable income to its shareholders (which is computed without regard to the dividends paid deduction or net capital gain and which does not necessarily equal net income as calculated in accordance with generally accepted accounting principles).
The Trust contributed the net proceeds from the IPO to Physicians Realty L.P. (the Operating Partnership), a Delaware limited partnership, and is the sole general partner of the Operating Partnership. The Trusts operations are conducted through the Operating Partnership and wholly-owned and majority-owned subsidiaries of the Operating Partnership. The Trust, as the general partner of the Operating Partnership, controls the Operating Partnership and consolidates the assets, liabilities and results of operations of the Operating Partnership.
As a REIT, the Trust generally will not be subject to federal income tax to the extent it distributes qualifying dividends to its shareholders. If the Trust fails to qualify as a REIT in any taxable year, it will be subject to federal income tax (including any applicable alternative minimum tax) on its taxable income at regular corporate income tax rates and generally will not be permitted to qualify for treatment as a REIT for federal income tax purposes for the four taxable years following the year during which qualification is lost unless the Internal Revenue Service grants the Trust relief under certain statutory provisions. Such an event could materially adversely affect the Trusts net income and net cash available for distribution to shareholders. However, the Trust intends to organize and operate in such a manner as to qualify for treatment as a REIT. Even if the Trust qualifies for taxation as a REIT, the Trust may be subject to state and local taxes on its income and property and federal income and excise taxes on its undistributed income.
The Trust is a self-managed REIT formed primarily to acquire, selectively develop, own and manage healthcare properties that are leased to physicians, hospitals and healthcare delivery systems.
Initial Public Offering and Formation Transactions
Concurrently with the completion of the IPO, the Trust acquired, through a series of contribution transactions, the entities that own the 19 properties that comprised the Trusts initial properties from four healthcare real estate funds (the Ziegler Funds), as well as certain operating assets and liabilities. We determined that the Zeigler Funds constitute our accounting predecessor (the Predecessor). The Predecessor, which is not a legal entity, is comprised of the four Zeigler Funds that owned directly or indirectly interest in entities that owned the initial 19 properties in the Trusts portfolio. The combined historical data for the predecessor is not necessarily indicative of the Trusts future financial position or results of operations. In addition, at the completion of the IPO, the Trust entered into a shared services agreement with B.C. Ziegler & Company (Ziegler) pursuant to which Ziegler provides office space, IT support, accounting support and other services to the Trust in exchange for an annual fee.
To acquire the ownership interests in the entities that own the 19 properties included in the Trusts initial properties, and certain other operating assets and liabilities, from the Ziegler Funds, the Operating Partnership issued to the Ziegler Funds an aggregate of 2,744,000 common units of partnership interest (OP Units), having an aggregate value of approximately $31.6 million based on the price to the public per share in the IPO and paid approximately $36.9 million of outstanding indebtedness related to our initial properties. These formation transactions were effected concurrently with the completion of the IPO.
The net proceeds from the IPO, inclusive of shares issued pursuant to the exercise of the underwriters overallotment option, were approximately $123.8 million (after deducting the underwriting discount and expenses of the IPO and the formation transactions
payable by the Trust). The Trust contributed the net proceeds of the IPO to the Operating Partnership in exchange for 11,753,597 OP Units and at September 30, 2013 owned a 76.4% interest in the Operating Partnership. The Operating Partnership used a portion of the IPO proceeds received from the Trust to repay approximately $36.9 million of outstanding indebtedness and to purchase the 50% interest in the Arrowhead Commons property not owned by the Ziegler Funds for approximately $850,000, after which the Operating Partnership became the 100% owner of the property, and to pay certain expenses related to debt transfers and our senior secured revolving credit facility. The balance of the net proceeds was invested in investment properties.
The Trust is a self-managed REIT and conducts its operations through the Operating Partnership and principally through wholly-owned and majority-owned subsidiaries of the Operating Partnership.
Because the IPO and the formation transactions were completed on July 24, 2013, and prior to completion of the IPO we had no operations, the Trusts balance sheet as of December 31, 2012 reflects the financial condition of the Predecessor, while the balance sheet as of September 30, 2013 reflects the financial condition of the Trust. The results of operation for the three and nine months ended September 30, 2013 reflect the results of operations of the Predecessor (through July 23, 2013) and of the Trust from July 24, 2013 through September 30, 2013. References in these notes to the condensed consolidated and combined financial statements to Physicians Realty Trust signify the Trust for the period from July 24, 2013, the date of completion of the IPO and the Formation Transaction, and of the Predecessor for all prior periods. The following is a summary of the Predecessor Statement of Operations for the period from July 1, 2013 through July 23, 2013, and for the period from January1, 2013 through July 23, 2013 (in thousands). These amounts are included in the condensed consolidated and combined statement of operations herein for the three and nine months ended September 30, 2013.
|
|
July 1, 2013 through |
|
January 1, 2013 |
| ||
|
|
|
|
|
| ||
Revenues: |
|
|
|
|
| ||
Rental revenues |
|
$ |
476 |
|
$ |
5,508 |
|
Expense recoveries |
|
168 |
|
1,769 |
| ||
Other revenues |
|
1 |
|
6 |
| ||
Total revenues |
|
645 |
|
7,283 |
| ||
Expenses: |
|
|
|
|
| ||
Management fees |
|
|
|
475 |
| ||
General and administrative |
|
27 |
|
249 |
| ||
Operating expenses |
|
225 |
|
2,673 |
| ||
Depreciation and amortization |
|
196 |
|
2,173 |
| ||
Total expenses |
|
448 |
|
5,570 |
| ||
Operating income |
|
197 |
|
1,713 |
| ||
Interest expense |
|
191 |
|
2,479 |
| ||
Change in fair value of derivatives, net |
|
|
|
(190 |
) | ||
Net income/(loss) |
|
$ |
6 |
|
$ |
(576 |
) |
Note 2Summary of Significant Accounting Policies
The accompanying unaudited condensed consolidated and combined financial statements reflect all adjustments which are, in the opinion of management, necessary for a fair presentation of the results for the periods ended September 30, 2013 and 2012 pursuant to the instructions to Form 10-Q and Article 10 of Regulation S-X. All such adjustments are of a normal recurring nature. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (GAAP) have been condensed or omitted pursuant to such rules and regulations. These financial statements should be read in conjunction with the audited financial statements included in the Trusts final prospectus dated July 18, 2013 filed with the Securities and Exchange Commission on July 19, 2013. Operating results for interim periods are not necessarily indicative of results that may be expected for the entire year ending December 31, 2013.
Classification of Assets and Liabilities
The financial affairs of the Trust generally do not involve a business cycle since the realization of assets and the liquidation of liabilities are usually dependent on the Trusts circumstances. Accordingly, the classification of current assets and current liabilities is not considered appropriate and has been omitted from the condensed consolidated and combined statements of assets and liabilities.
Noncontrolling Interests
In connection with the closing of the IPO, the Trust and the Operating Partnership completed related formation transactions pursuant to which the Operating Partnership acquired from the Ziegler Funds, the Ziegler Funds ownership interests in 19 medical office buildings located in ten states in exchange for an aggregate of 2,744,000 OP Units and the payment of approximately $36.9 million of debt related to such properties.
In connection with the acquisition of a surgical center hospital in the New Orleans, Louisiana metropolitan area for approximately $37.5 million, on September 30, 2013, the Trust partially funded the purchase price by issuing 954,877 OP Units valued at approximately $11.5 million on the date of issuance.
Noncontrolling interests in the Trust represent OP Units held by the Predecessors prior investors and other investors. As of September 30, 2013, the Trust held a 76.4% interest in the Operating Partnership. As the sole general partner and the majority interest holder, the Trust consolidates the financial position and results of operation of the Operating Partnership.
Holders of OP Units may not transfer their units without the Trusts prior written consent, as general partner of the Operating Partnership. Beginning on the first anniversary of the issuance of OP Units, OP Unit holders may tender their units for redemption by the Operating Partnership in exchange for cash equal to the market price of the Trusts common shares at the time of redemption or, for common shares on a one-for-one basis. Accordingly, the Trust presents the OP Units of the Operating Partnership held by the Predecessors prior investors and other investors as noncontrolling interests within equity in the consolidated balance sheet.
Dividends and Distributions
On September 30, 2013, the Trusts Board of Trustees declared an initial, prorated cash dividend of $0.18 per share for the quarterly period from July 19, 2013 (the date of the IPO) through September 30, 2013, which is equivalent to a full quarterly dividend of $0.225 per share. The dividend was paid on November 1, 2013 to common shareholders and common OP unit holders of record on October 18, 2013.
Impairment of Intangible and Long-Lived Assets
The Trust evaluates the recoverability of the recorded amount of intangible and long-lived assets whenever events or changes in circumstances indicate that the recorded amount of an asset may not be fully recoverable. Impairment is assessed when the undiscounted expected future cash flows derived from an asset are less than its carrying amount. If we determine that an asset is impaired, the impairment to be recognized is measured as the amount by which the recorded amount of the asset exceeds its fair value. Assets to be disposed of are reported at the lower of the recorded amount or fair value less cost to sell. Fair value is determined using a discounted future cash flow analysis.
The Trust did not recognize any impairment for the three months ended September 30, 2013, nor did the Predecessor in the comparative period presented.
Rental Revenue
Rental revenue is recognized on a straight-line basis over the terms of the related leases when collectability is reasonably assured. Recognizing rental revenue on a straight-line basis for leases may result in recognizing revenue for amounts more or less than amounts currently due from tenants. Amounts recognized in excess of amounts currently due from tenants are included in other assets and were $1.4 million and $1.3 million as of September 30, 2013 and December 31, 2012, respectively. If the Trust determines that collectability of straight-line rents is not reasonably assured, the Trust limits future recognition to amounts contractually owed and, where appropriate, establishes an allowance for estimated losses. Rental revenue is reduced by amortization of lease inducements and above market rents on certain leases. Lease inducements and above market rents are amortized over the average remaining life of the lease.
Expense Recoveries
Expense recoveries relate to tenant reimbursement of real estate taxes, insurance and other operating expenses that are recognized as expense recovery revenue in the period the applicable expenses are incurred. The reimbursements are recorded at gross, as the Trust is generally the primary obligor with respect to real estate taxes and purchasing goods and services from third-party suppliers and has discretion in selecting the supplier and bears the credit risk of tenant reimbursement.
The Trust has certain tenants with absolute net leases. Under these lease agreements, the tenant is the responsible for operating and building expenses. For absolute net leases, the Trust does not recognize expense recoveries
Earnings Per Share
The Trust calculates earnings per share based upon the weighted average shares outstanding during the period beginning July 24, 2013. Diluted net income per share is calculated after giving effect to all potential diluted shares outstanding during the period. There were 3,698,877 potentially dilutive shares outstanding related to the issuance of OP Units held by noncontrolling interests during the three and nine month periods ended September 30, 2013. However, the shares were excluded from the computation of diluted shares as their impact would have been anti-dilutive. As a result, the number of diluted outstanding shares was treated equal to the number of outstanding shares.
Management Estimates
The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the combined financial statements and the amounts of revenue and expenses reported in the period. Significant estimates are made for the valuation of real estate and intangibles, valuation of financial instruments, impairment assessments and fair value assessments with respect to purchase price allocations. Actual results could differ from these estimates.
Reclassifications
Certain prior period amounts have been reclassified to conform to the current financial statement presentation, with no effect on the consolidated financial position or results of operations.
Note 3Acquisitions and Dispositions
On July 24, 2013, in connection with the completion of the IPO and formation transactions, Physicians Realty L.P. purchased the 50% joint venture equity interest in Arizona 23 (Arrowhead Commons) not already owned by the Ziegler Funds for approximately $850,000, resulting in 100% ownership of this property by the Operating Partnership.
On August 30, 2013, we completed the acquisition of a 40,000 square foot medical office building and a 77,000 square foot, 40-bed acute care surgical hospital located in El Paso, Texas for approximately $40 million. The Trust also purchased a right of first refusal to finance development on land adjacent to the hospital. The surgical hospital portion of the facility is 100% leased to one tenant until 2028, with annual rent escalations of 3%. The medical office building portion of the facility is 100% leased to one tenant until 2018, with annual rent escalations of 3%. The purchase price of this medical office building and hospital was allocated to the assets and liabilities acquired consisting of tangible property and identifiable intangible assets based on the respective fair values at acquisition, as determined by an independent appraisal. Intangible assets include the value of in-place lease at the time of the acquisition and will be amortized over the remaining lease term of approximately 12 years. The initial acquisition accounting was as follows (in thousands):
Land |
|
$ |
3,800 |
|
Building and improvements |
|
28,100 |
| |
Intangibles |
|
8,100 |
| |
Total |
|
$ |
40,000 |
|
On September 18, 2013, the Trust completed the acquisition of a 66-bed post-acute care specialty hospital located in Plano, Texas for approximately $18.2 million. The hospital is 100% leased to a single tenant. The term of the lease expires December 31, 2027, and the
tenant has one five year extension option. The tenants obligations under the lease are guaranteed by its parent, which operates 26 hospitals in nine states. The purchase price was allocated to the assets and liabilities acquired consisting of tangible property and identifiable intangible assets based on the respective fair values at acquisition, as determined by an independent appraisal. Intangible assets include the value of an in-place lease and an above-market lease at the time of the acquisition and will be amortized over the remaining lease term of approximately 9 years. The initial acquisition accounting was as follows (in thousands):
Land |
|
$ |
3,400 |
|
Building and improvements |
|
11,700 |
| |
In-place leases |
|
3,100 |
| |
Total |
|
$ |
18,200 |
|
On September 30, 2013, we completed the acquisition of a hospital in the New Orleans, Louisiana metropolitan area for approximately $37.5 million. We funded the purchase price with borrowings under the senior secured revolving credit facility, proceeds of the IPO and the issuance of 954,877 OP Units to the seller valued at approximately $11.5 million on the date of issuance (based on the average three day closing price of our common shares prior to the close). The hospital is leased until 2028 with initial rent equal to $3.0 million per year, with annual rent escalations of 3%. The purchase price of this hospital was allocated to the assets and liabilities acquired consisting of tangible property and identifiable intangible assets based on the respective fair values at acquisition, as determined by an independent appraisal. Intangible assets include the value of in-place lease at the time of the acquisition and will be amortized over the remaining lease term of approximately 15 years. The initial acquisition accounting was as follows (in thousands):
Building and improvements |
|
$ |
34,200 |
|
In-place leases |
|
3,300 |
| |
Total |
|
$ |
37,500 |
|
On September 30, 2013, we completed the acquisition of an approximately 52,000 square foot outpatient care building located in Oklahoma City, Oklahoma for approximately $15.6 million. The property is leased until 2023 with annual rent escalations of 2%. The purchase price was allocated to the assets and liabilities acquired consisting of tangible property and identifiable intangible assets based on the respective fair values at acquisition, as determined by an independent appraisal. Intangible assets include the value of in-place lease at the time of the acquisition and will be amortized over the average remaining lease term of approximately 10 years. The initial acquisition accounting was as follows (in thousands):
Land |
|
$ |
1,300 |
|
Building and improvements |
|
12,700 |
| |
In-place leases |
|
1,600 |
| |
Total |
|
$ |
15,600 |
|
On September 30, 2013, the Trust sold a 4,000 square foot medical office building condominium unit located in Florida for approximately $0.5 million. There is one remaining condominium unit or 2,000 square feet at this location.
Note 4Intangibles
The following is a summary of the carrying amount of intangible assets as of September 30, 2013 and December 31, 2012 (in thousands):
|
|
September 30, 2013 |
|
December 31, 2012 |
| ||||||||||||||
|
|
Cost |
|
Accumulated |
|
Net |
|
Cost |
|
Accumulated |
|
Net |
| ||||||
In-place leases |
|
$ |
26,073 |
|
$ |
(7,525 |
) |
$ |
18,548 |
|
$ |
12,150 |
|
$ |
(6,907 |
) |
$ |
5,243 |
|
Above market leases |
|
2,180 |
|
(12 |
) |
2,168 |
|
|
|
|
|
|
| ||||||
Total |
|
$ |
28,253 |
|
$ |
(7,537 |
) |
$ |
20,716 |
|
$ |
12,150 |
|
$ |
(6,907 |
) |
$ |
5,243 |
|
Amortization expense related to intangibles was $0.6 million for each of the nine month periods ended September 30, 2013 and 2012. Amortization expense related to intangibles was $0.2 million for each of the three months ended September, 30, 2013 and 2012. Future amortization of the intangible assets as of September 30, 2013, is as follows (in thousands):
Year Ending December 31: |
|
|
| |
2013 |
|
$ |
567 |
|
2014 |
|
2,217 |
| |
2015 |
|
2,185 |
| |
2016 |
|
2,172 |
| |
2017 |
|
1,996 |
| |
Thereafter |
|
11,579 |
| |
Total |
|
$ |
20,716 |
|
Note 5Debt
The following is a summary of debt as of September 30, 2013 and December 31, 2012 (in thousands):
|
|
September 30, |
|
December 31, |
| ||
|
|
2013 |
|
2012 |
| ||
$75 million senior secured revolving credit facility bearing interest at floating rates, due August 2016 |
|
$ |
19,850 |
|
$ |
|
|
Mortgage notes, bearing fixed interest from 5.35% to 6.58% and due in 2017 with a balloon payment of $23,748, and 2018 with a balloon payment of $6,169 |
|
32,125 |
|
34,457 |
| ||
Mortgage notes, bearing variable interest from 2.44% to 2.94% and due in 2016 with a balloon payment of $7,683 and in 2017 with a balloon payment of $5,680. |
|
14,550 |
|
45,536 |
| ||
Mezzanine debt bearing interest at 12.0 % and due 2013 |
|
|
|
4,400 |
| ||
Line of credit bearing variable interest at 4.25% and due in 2012 |
|
|
|
96 |
| ||
Total debt |
|
$ |
66,525 |
|
$ |
84,489 |
|
On August 29, 2013, the Trust and the Operating Partnership entered into a Credit Agreement with Regions Bank, as Administrative Agent, Regions Capital Markets, as Sole Lead Arranger and Sole Book Runner, and various other lenders in connection with a $75 million senior secured revolving credit facility (the Credit Agreement). Subject to satisfaction of certain conditions, including additional lender commitments, we have the option to increase the borrowing capacity under the revolving credit facility to up to $250
million. The amount available to us under the Credit Agreement is subject to certain limitations including, but not limited to, the appraised value of the pledged properties that comprise the borrowing base of the credit facility.
The Credit Agreement has a three-year term with an initial maturity date of August 29, 2016. Subject to the terms of the Credit Agreement, the Operating Partnership has the option to extend the term of the Credit Agreement to August 29, 2017.
The obligations of the Operating Partnership under the Credit Agreement are guaranteed by us and certain of our subsidiaries. In addition, the Credit Agreement provides for security in the form of, among other things, mortgage liens on certain properties owned by the Operating Partnership that comprise the borrowing base. As of September 30, 2013, seven properties were included in the borrowing base with a net book value of $69.4 million
The Credit Agreement provides for revolving credit loans to the Operating Partnership. Base Rate Loans, Adjusted LIBOR Rate Loans and Letters of Credit (each, as defined in the Credit Agreement) will be subject to interest rates, based upon the consolidated leverage ratio of the Trust, the Operating Partnership and its subsidiaries as follows:
Consolidated Leverage Ratio |
|
Adjusted LIBOR Rate Loans and |
|
Base Rate Loans |
<35% |
|
LIBOR + 2.65% |
|
Base Rate + 1.65% |
>35% and <45% |
|
LIBOR + 2.85% |
|
Base Rate + 1.85% |
>45% and <50% |
|
LIBOR + 2.95% |
|
Base Rate + 1.95% |
>50% |
|
LIBOR + 3.40% |
|
Base Rate + 2.40% |
The Operating Partnership may, at any time, voluntarily prepay any loan under the Credit Agreement in whole or in part without premium or penalty.
The Credit Agreement contains financial covenants that, among other things, require compliance with loan-to-value, leverage and coverage ratios and maintenance of minimum tangible net worth, as well as covenants that may limit the Trusts and the Operating Partnerships ability to incur additional debt or make distributions. The Credit Agreement also contains customary events of default. Any event of default, if not cured or waived, could result in the acceleration of any outstanding indebtedness under the Credit Agreement.
Scheduled principal payments due on debt as of September 30, 2013, are as follows (in thousands):
Year Ending December 31: |
|
|
| |
2013 |
|
$ |
249 |
|
2014 |
|
1,022 |
| |
2015 |
|
1,063 |
| |
2016 |
|
28,435 |
| |
2017 |
|
29,586 |
| |
Thereafter |
|
6,170 |
| |
Total Payments |
|
$ |
66,525 |
|
Note 6Stock-based Compensation
We follow ASC 718 in accounting for our share-based payments. This guidance requires measurement of the cost of employee services received in exchange for stock compensation based on the grant-date fair value of the employee stock awards. This cost is
recognized as compensation expense ratably over the employees requisite service period. Incremental compensation costs arising from subsequent modifications of awards after the grant date must be recognized when incurred.
For all service awards, we record compensation expense for the entire award on a straight-line basis (or, if applicable, on the accelerated method) over the requisite service period.
In connection with the IPO, we adopted the 2013 Equity Incentive Plan which made available 600,000 restricted shares to be administered by the Compensation, Nomination and Governance Committee of the Board of Trustees. The committee will have broad discretion in administering the terms of the plan. Restricted shares are eligible for dividends as well as the right to vote. We granted 250,000 restricted common shares upon completion of the IPO under our 2013 Equity Incentive Plan at a value per share of $11.50 and total value of $2.9 million with a vesting period of three years. For the three and nine months ended September 30, 2013, we recognized non-cash share compensation of $0.2 million. Unrecognized compensation expense at September 30, 2013 was $2.7 million. Our compensation expense recorded in connection with grants of restricted stock reflects as initial estimated cumulative forfeiture rate 0% over the requisite service period of the awards. That estimate will be revised if subsequent information indicates that the actual number of awards expected to vest is likely to differ from previous estimates.
Note 7Fair Value Measurements
Accounting standards require certain assets and liabilities be reported at fair value in the financial statements and provides a framework for establishing that fair value. The framework for determining fair value is based on a hierarchy that prioritizes the valuation techniques and inputs used to measure fair value.
In general, fair values determined by Level 1 inputs use quoted prices in active markets for identical assets or liabilities that the Trust has the ability to access. Fair values determined by Level 2 inputs use other inputs that are observable, either directly or indirectly. These Level 2 inputs include quoted prices for similar assets and liabilities in active markets, and other inputs such as interest rates and yield curves that are observable at commonly quoted intervals. Significant Level 2 inputs include interest rate swaps.
Level 3 inputs are unobservable inputs, including inputs that are available in situations where there is little, if any, market activity for the related asset. These level 3 fair value measurements are based primarily on managements own estimates using pricing models, discounted cash flow methodologies, or similar techniques taking into account the characteristics of the asset. In instances where inputs used to measure fair value fall into different levels of the fair value hierarchy, fair value measurements in their entirety are categorized based on the lowest level input that is significant to the valuation. The \ assessment of the significance of particular inputs to these fair value measurements requires judgment and considers factors specific to each asset or liability.
We measure our interest rate swaps at fair value on a recurring basis. The fair value of ($0.4) million and $(0.6) million as of September 30, 2013 and December 31, 2012, respectively, is based on primarily level 2 inputs described above.
Our derivative instruments (Note 8) are not traded on an exchange. We obtained an estimate of fair value of the swaps from the counterparties. The trust then tested the fair value against a fair value determined by a methodology that included using the income approach to value the derivatives, using observable Level 2 market expectations at the measurement date and standard valuation techniques to convert future amounts to a single present amount (discounted) assuming that participants are motivated, but not compelled to transact. Level 2 inputs for the swap valuations were limited to quoted prices for similar assets or liabilities in active markets (specifically future contracts) and inputs other than quoted prices that were observable for the asset or liability (specifically LIBOR cash and swap rates, implied volatility for options, caps and floors, basis swap adjustments and credit risk at commonly quoted intervals). Mid-market pricing was used as a practical expedient for fair value measurements. Key inputs, including the cash rates for very short-term, futures rates and swap rates beyond the derivative maturities were bootstrapped to provide spot rates at resets specified by the swaps (reset rates were then further adjusted by the basis swaps, if necessary). Inputs were collected from Bloomberg as the last price on the last market day of the period. The same rates used to bootstrap the yield curves were used to discount the future cash flows prior to the credit risk effect for both the Trust and the credit risk of its counterparty when determining the fair value of derivatives under generally accepted accounting principles. The fair values resulting from the separate calculations were not significantly different.
Both direct and indirect observable inputs may be used to determine the fair value of the positions classified as Level 2 assets and liabilities. As a result, the unrealized gains and losses for these asset and liabilities presented above may include changes in fair value that were attributable to both direct and indirect observable inputs. Changes in fair value of the interest rate swaps totaled $(0.02) million and $(0.2) million and $(0.2) million and $(0.1) million for the three and nine months ended September 30, 2013 and 2012, respectively, and are included in the condensed consolidated and combined statement of operations.
The Trust also has assets that under certain conditions are subject to measurement at fair value on a non-recurring basis. This generally includes assets subject to impairment. There were no such assets measured at fair value as of September 30, 2013.
The following table sets forth by level within the fair value hierarchy of our assets and liabilities that were accounted for on a nonrecurring basis as of December 31, 2012 (in thousands).
|
|
Nonrecurring Fair Value Measurements |
| |||||||||||||
|
|
Fair Value |
|
Quoted Prices |
|
Significant |
|
Significant |
|
Total Gains |
| |||||
Medical office buildings |
|
$ |
3,589 |
|
$ |
|
|
$ |
|
|
$ |
3,589 |
|
$ |
(615 |
) |
Land |
|
1,210 |
|
|
|
|
|
1,210 |
|
(232 |
) | |||||
Property under development |
|
675 |
|
|
|
|
|
675 |
|
(90 |
) | |||||
|
|
$ |
5,474 |
|
$ |
|
|
$ |
|
|
$ |
5,474 |
|
$ |
(937 |
) |
The impairment of the medical office buildings referenced above primarily resulted from declines in current and projected operating results and cash flows of the properties.
The following table summarizes the quantitative inputs and assumptions used for items categorized in Level 3 for the fair value hierarchy as of December 31, 2012. There were no changes in the quantitative inputs and assumptions used for items categorized in Level 3 for the fair hierarchy as of September 30, 2013. The disclosure below excludes information on unobservable inputs that are non-quantitative such as unadjusted prices from recent transactions or third party valuations.
Asset Category |
|
Fair value at |
|
Valuation |
|
Unobservable |
|
Ranges |
| |
Investment in real estate properties |
|
$ |
4,799 |
|
Discounted cash flow |
|
Discount rate |
|
10.7-13.5% |
|
Property under development |
|
$ |
675 |
|
Market comparable/ Discounted cash flow |
|
Capitalization rate |
|
9-10% |
|
The carrying amounts of cash and cash equivalents, tenant receivables, payables, and accrued interest are reasonable estimates of fair value because of the short maturities of these instruments. Fair values for notes payable are estimates based on rates currently prevailing for similar instruments of similar maturities.
The following table presents the fair value of other financial instruments (in thousands). The swaps are measured at fair value on a recurring basis.
|
|
September 30, |
|
December 31, |
| ||||||||
|
|
2013 |
|
2012 |
| ||||||||
|
|
(unaudited) |
|
|
|
|
| ||||||
|
|
Carrying |
|
Fair |
|
Carrying |
|
Fair |
| ||||
Cash |
|
$ |
4,233 |
|
$ |
4,233 |
|
$ |
2,614 |
|
$ |
2,614 |
|
Debt |
|
$ |
46,675 |
|
$ |
47,192 |
|
$ |
84,489 |
|
$ |
86,982 |
|
Interest rate swapsLiabilities |
|
$ |
437 |
|
$ |
437 |
|
$ |
643 |
|
$ |
643 |
|
Note 8Derivative Financial Instruments
We are exposed to certain risks in the normal course of our business operations. One risk relating to the variability of interest on variable rate debt is managed through the use of derivatives. All derivative financial instruments are reported in the balance sheet at fair value.
Generally, we enter into swap relationships such that changes in the fair value or cash flows of items and transactions being hedged are expected to be offset by corresponding changes in the values of the derivatives.
The Trust and the Predecessor held swaps to pay fixed/receive variable interest rates swaps with a total notional amount of $8.0 million and $25.6 million as of September 30, 2013 and December 31, 2012, respectively. Gains recognized on the interest rate swaps of $0.02 million were included in change in fair value of derivatives, net in the condensed consolidated and combined statements of operations for the three month periods ended September 30, 2013, no gain was recognized for the three months ended September 30, 2012 and a gain of $0.2 million and $0.06 million were recognized for the nine month periods ended September 30, 2013 and 2012, respectively.
Note 9Operating Leases
The Trust is lessor of medical office buildings and other healthcare facilities. Leases have expirations from 2013 through 2028. As of September 30, 2013, the future minimum rental payments on noncancelable leases were as follows (in thousands):
Year Ending December 31: |
|
|
| |
2013 |
|
$ |
4,864 |
|
2014 |
|
19,349 |
| |
2015 |
|
19,633 |
| |
2016 |
|
19,555 |
| |
2017 |
|
18,614 |
| |
Thereafter |
|
141,456 |
| |
Total Payments |
|
$ |
223,471 |
|
Note 10Earnings Per Share
The following table shows the amounts used in computing our basic and diluted earnings per share. As the three and nine months ended September 30, 2013 resulted in a net loss, there is no dilution to earnings per share (in thousands, except share and per share data):
|
|
Three Months |
|
Nine Months |
| ||
|
|
2013 |
|
2013 |
| ||
Numerator for earnings per share basic and diluted: |
|
|
|
|
| ||
Net loss |
|
$ |
(1,416 |
) |
$ |
(1,998 |
) |
Less: (Income)/loss allocable to noncontrolling interests - Predecessor |
|
(6 |
) |
576 |
| ||
Less: Loss allocable to noncontrolling interests |
|
262 |
|
262 |
| ||
Numerator for earnings per share basic and diluted |
|
$ |
(1,160 |
) |
$ |
(1,160 |
) |
Denominator for earnings per share - basic and diluted shares: |
|
11,486,011 |
|
11,486,011 |
| ||
Basic and diluted earnings per share |
|
$ |
(0.10 |
) |
$ |
(0.10 |
) |
Note 11 Subsequent Events
On October 4, 2013, the Trust completed the acquisition of a 20,319 square foot medical office building and ambulatory surgery center located in Pensacola, Florida for approximately $6.9 million. The purchase price was funded with borrowings on our senior secured revolving credit facility.
On November 6, 2013, the Trust entered into an agreement to acquire a 40.42% joint venture equity interest in the Valley West medical office building not owned by the Trust for approximately $3.0 million, resulting in our 100.0% ownership of this property.
On November 6, 2013, the Trust entered into an agreement to acquire a 35% joint venture equity interest in the Remington Medical Commons property not owned by us for approximately $1.1 million, resulting in our 100.0% ownership of this property.
On November 7, 2013, the Trust entered into an agreement to acquire four medical office buildings located in Atlanta, GA, from an unrelated seller for approximately $20.8 million.
On November 8, 2013, the Trust and the lenders agreed to increase the maximum borrowing capacity under the senior secured revolving credit facility to $90 million from $75 million.
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations
References to we, us, our, our company, the Trust, and Physicians Realty refer to Physicians Realty Trust, a Maryland real estate investment trust, together with its consolidated subsidiaries, including Physicians Realty L.P., a Delaware limited partnership, of which Physicians Realty Trust is the sole general partner and which we refer to in this Quarterly Report on Form 10-Q as our Operating Partnership.
Forward-Looking Statements
The following discussion should be read in conjunction with the consolidated financial statements and notes thereto appearing elsewhere in this report. We make statements in this report that are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (set forth in Section 27A of the Securities Act of 1933, as amended (the Securities Act), and Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act)). In particular, statements pertaining to our capital resources, portfolio performance and results of operations contain forward-looking statements. Likewise, our pro forma financial statements and our statements regarding anticipated market conditions are forward-looking statements. You can identify forward-looking statements by the use of forward-looking terminology such as believes, expects, may, will, should, seeks, approximately, intends, plans, pro forma, estimates or anticipates or the negative of these words and phrases or similar words or phrases which are predictions of or indicate future events or trends and which do not relate solely to historical matters. You can also identify forward-looking statements by discussions of strategy, plans or intentions.
Forward-looking statements involve numerous risks and uncertainties and you should not rely on them as predictions of future events. Forward-looking statements depend on assumptions, data or methods which may be incorrect or imprecise and we may not be able to realize them. We do not guarantee that the transactions and events described will happen as described (or that they will happen at all). The following factors, among others, could cause actual results and future events to differ materially from those set forth or contemplated in the forward-looking statements:
· general economic conditions;
· adverse economic or real estate developments, either nationally or in the markets in which our properties are located;
· our failure to generate sufficient cash flows to service our outstanding indebtedness;
· fluctuations in interest rates and increased operating costs;
· the availability, terms and deployment of debt and equity capital, including our senior secured revolving credit facility;
· our ability to make distributions on our shares of beneficial interest;
· general volatility of the market price of our common shares;
· our limited operating history;
· changes in our business or strategy;
· our dependence upon key personnel whose continued service is not guaranteed;
· our ability to identify, hire and retain highly qualified personnel in the future;
· the degree and nature of our competition;
· changes in governmental regulations, tax rates and similar matters;
· defaults on or non-renewal of leases by tenants;
· decreased rental rates or increased vacancy rates;
· difficulties in identifying healthcare properties to acquire and completing acquisitions;
· competition for investment opportunities;
· our failure to successfully develop, integrate and operate acquired properties and operations;
· the impact of our investment in joint ventures;
· the financial condition and liquidity of, or disputes with, joint venture and development partners;
· changes in GAAP;
· lack of or insufficient amounts of insurance;
· other factors affecting the real estate industry generally;
· our failure to qualify and maintain our qualification as a REIT for U.S. federal income tax purposes;
· limitations imposed on our business and our ability to satisfy complex rules in order for us to qualify as a REIT for U.S. federal income tax purposes; and
· changes in governmental regulations or interpretations thereof, such as real estate and zoning laws and increases in real property tax rates and taxation of REITs.
Overview
We are a self-managed healthcare real estate company organized in April 2013 to acquire, selectively develop, own and manage healthcare properties that are leased to physicians, hospitals and healthcare delivery systems. We invest in real estate that is integral to providing high quality healthcare services. Our properties are typically located on a campus with a hospital or other healthcare facilities or strategically located and affiliated with a hospital or other healthcare facilities. We believe the impact of government programs and continuing trends in the healthcare industry create attractive opportunities for us to invest in healthcare related real estate. Our management team has significant public healthcare REIT experience and has long established relationships with physicians, hospitals and healthcare delivery system decision makers that we believe will provide quality investment and growth opportunities. Our principal investments include medical office buildings, outpatient treatment facilities, acute and post-acute care hospitals, as well as other real estate integral to health care providers. We seek to generate attractive risk-adjusted returns for our shareholders through a combination of stable and increasing dividends and potential long-term appreciation in the value of our properties and our common shares. We intend to elect and qualify to be taxed as a REIT for federal income tax purposes commencing with our short taxable year ending December 31, 2013.
We completed our underwritten initial public offering (IPO) and related formation transactions on July 24, 2013, issuing 11,753,597 common shares, including shares issued upon exercise of the underwriters over-allotment option, and received net proceeds of approximately $123.8 million, after deducting the underwriting discounts and expenses of the IPO payable by us. We contributed the net proceeds of the IPO to our Operating Partnership in exchange for 11,753,597 common units of partnership interest in our Operating Partnership (OP Units) and at September 30, 2013, we owned a 76.4% interest in our Operating Partnership. Our Operating Partnership used the net proceeds of the IPO to repay approximately $36.9 million of outstanding indebtedness related to properties in our initial portfolio and to purchase the 50% interest in the Arrowhead Common property not owned by the Ziegler Funds for approximately $850,000, after which we became the 100% owner of that property, and to pay certain expenses related to debt and transfer and our senior secured revolving credit facility.
Prior to completion of our IPO on July 24, 2013, we had no operations or assets, other than $1,000 of cash from our initial capitalization. We acquired 19 properties upon the completion of our IPO and related formation transactions on July 24, 2013. Since the completion of our IPO, we have acquired 5 additional properties containing an aggregate of 305,449 square feet. At September 30, 2013, our portfolio consisted of 24 properties located in 12 states with approximately 829,497 net leasable square feet, which were approximately 90.3% leased with a weighted average remaining lease term of approximately 8.6 years. We receive a cash rental stream from these healthcare providers under our leases. Approximately 98% of the annualized base rent payments from our properties as of September 30, 2013 are from triple net leases, pursuant to which the tenants are responsible for all operating expenses relating to the property, including but not limited to real estate taxes, utilities, property insurance, routine maintenance and repairs, and property management. This structure helps insulate us from increases in certain operating expenses and provides more predictable cash flow. We seek to structure our triple-net leases to generate attractive returns on a long-term basis. Our leases typically have initial terms of 5 to 15 years and include annual rent escalators of approximately 2%. Our operating results depend significantly upon the ability of our tenants to make required rental payments. We believe that our portfolio of medical office buildings and other healthcare facilities will enable us to generate stable cash flows over time because of the diversity of our tenants, staggered lease expiration schedule, long-term leases, and low historical occurrence of tenants defaulting under their leases. As of September 30, 2013, leases representing 1.2%, 2.5% and 1.3% of leasable square feet in our portfolio will expire in 2013, 2014 and 2015, respectively.
We did not conduct business operations prior to completion of our IPO on July 24, 2013, therefore, the financial information herein for periods prior to July 24, 2013 reflects the operations of the four healthcare real estate funds managed by B.C. Ziegler & Company, which we refer to as the Ziegler Funds, from whom we acquired the equity interests in the 19 properties that constituted our initial properties upon completion of our IPO and formation transactions. We determined the Ziegler Funds to be our accounting
predecessor (the Predecessor). The financial information herein since July 24, 2013 reflect our operations since completion of the IPO and formation transactions and include the results of operations of the five acquisition properties described above from the date of our acquisition.
We have entered into a $75 million senior secured revolving credit facility and intend to use borrowings under the facility to finance future acquisitions and developments, fund tenant improvements, leasing commissions to third parties, and capital expenditures, provide for working capital and for other general corporate purposes. At September 30, 2013, we had approximately $46.7 million of mortgage indebtedness outstanding secured by first mortgages on certain of our properties and approximately $19.9 million of outstanding borrowings under our senior secured revolving credit facility.
Concurrently with the completion of the IPO, we entered into a series of contribution transaction where we acquired the entities that own 19 properties that comprised our initial portfolio from the Ziegler Funds, as well as certain operating assets and liabilities, and issued to the Ziegler Funds an aggregate of 2,744,000 OP Units having an aggregate value of approximately $31.6 million based on the price to the public per share in the IPO and the payment of approximately $36.9 million of debt related to such properties. In addition, at the completion of the IPO, we entered into a shared services agreement with B.C. Ziegler & Company (Ziegler) pursuant to which Ziegler provides office space, IT support, accounting support and other services to us in exchange for an annual fee.
Following completion of our IPO and related formation transactions through September 30, 2013, we completed the acquisition of five healthcare properties as summarized below using proceeds from the IPO, borrowings under our senior secured revolving credit facility and issuance of OP Units.
Property |
|
Location |
|
Acquisition |
|
Square |
|
Purchase |
| |
Hospital |
|
El Paso, TX |
|
August 30, 2013 |
|
77,000 |
|
$ |
32,823,775 |
|
Medical Office Building |
|
El Paso, TX |
|
August 30, 2013 |
|
40,000 |
|
$ |
7,176,225 |
|
Long Term Acute Care |
|
Plano, TX |
|
September 18, 2013 |
|
75,442 |
|
$ |
18,200,000 |
|
Surgical Center Hospital |
|
New Orleans, LA |
|
September 30, 2013 |
|
60,000 |
|
$ |
37,500,000 |
|
Outpatient Care Building |
|
Oklahoma City, OK |
|
September 30, 2013 |
|
52,000 |
|
$ |
15,600,000 |
|
As partial payment of the purchase price for the hospital in New Orleans, Louisiana, described above, on September 30, 2013, we issued an aggregate of 954,877 OP Units to the sellers of that property valued at approximately $11.5 million (based on the average three-day closing price of our common shares prior to closing).
We are a self-managed REIT and conduct our operations through our Operating Partnership and wholly-owned subsidiaries of our Operating Partnership.
Components of Our Revenues, Expenses and Cash Flow
The financial information of our Predecessor, the Ziegler Funds, prior to completion of the IPO, reflects a different structure, principally relating to expenses, than our operations following the inception of operations upon completion of our IPO and as a result, the results of operations of the Predecessor and our results since our inception of operations may not be comparable. While the financial presentation of revenues pursuant to the leases at the properties in our initial portfolio and certain expenses, such as depreciation and amortization, are substantially consistent for the Predecessor and for us, the expense structure of our company since completion of the IPO and the formation transactions differs from the historical expense structure of the Predecessor. During the periods of financial information for the Predecessor, the Ziegler Funds had no direct employees and paid a fixed annual management fee to B.C. Ziegler & Company (Ziegler), which managed the operations of the Ziegler Funds. By contrast, as a self-managed REIT, we do not pay management fees to third parties (other than to third party property management companies with respect to certain of our properties) but rather we pay cash and other forms of compensation to our officers and employees. Also, effective upon completion of the formation transactions, we entered into a Shared Services Agreement with Ziegler pursuant to which we pay Ziegler a fixed annual fee for office space, IT support, accounting support and similar services. In addition, as a public reporting company,
we have incurred and expect to continue to incur certain expenses, such as legal and accounting expenses relating to SEC reporting and other matters that were not incurred historically by the Predecessor, which was not a public reporting company.
Revenues
Revenues consist primarily of the rental revenues and property operating expense recoveries we collect from tenants pursuant to our leases. Additionally, we recognize certain cash and non-cash revenues. These other cash and non-cash revenues are highlighted below.
Rental revenues. Rental revenues represent rent under existing leases that is paid by our tenants and straight-lining of contractual rents reduced by lease inducements and above market leases.
Expense recoveries. Certain of our leases require our tenants to make estimated payments to us to cover their proportional share of operating expenses, including but not limited to real estate taxes, property insurance, routine maintenance and repairs, utilities, and property management expenses. We collect these estimated expenses and are reimbursed by our tenants for any actual expenses in excess of our estimates or reimburse tenants if our collected estimates exceed our actual operating expenses. The net reimbursed operating expenses are included in revenues as expense recoveries.
We have certain tenants with absolute net leases. Under these lease agreements, the tenant is responsible for operating and building expenses. For absolute net leases, we do not recognize expense recoveries.
Other revenues. We sweep our excess cash balances into interest-bearing accounts which produce interest revenues.
Expenses
Expenses consist primarily of depreciation and amortization, operating expenses of our properties, the general and administrative costs associated with operating our business and costs we incur to acquire properties. In addition, we incur interest expenses on our borrowings.
Management fees. Ziegler and another subsidiary of the Ziegler Companies, Inc. historically charged a management fee to the Ziegler Funds. These management fees were discontinued upon our acquisition of our initial properties upon completion of our IPO and the formation transactions.
General and administrative. General and administrative expenses include certain expenses such as compensation, accounting, legal and other professional fees as well as certain other administrative and travel costs, and expenses related to bank charges, franchises taxes, corporate filing fees, exchange listing fees, officer and trustee insurance costs and other costs associated with being a public company. In addition, effective upon completion of the IPO, we entered into a Shared Services Agreement with Ziegler with respect to certain overhead expenses. See Certain Relationships and Related Transactions-Shared Services Agreement in our final prospectus. The fees paid under the Shared Services Agreement are included in general and administrative expenses.
Operating Expenses. Operating expenses include property operating expenses such as real estate taxes, property insurance, routine maintenance and repairs, utilities and property management expenses, some of which are reimbursed to us by tenants under the terms of triple net leases.
Depreciation and amortization. We incur depreciation and amortization expense on all of our long-lived assets. This non-cash expense is designed under generally accepted accounting principles, or GAAP, to reflect the economic useful lives of our assets.
Loss on sale of property under development. We record any gain or loss resulting from the sale of assets at the time of sale. We record any gains or losses resulting from the sale of assets at the time we enter into a definitive agreement for the sale of the asset.
Impairment losses. We periodically assess the carrying value of real estate investments and related intangible assets in accordance with ASC 360, Property, Plant, and Equipment (ASC 360), to determine if facts and circumstances exist that would suggest that assets might be impaired or that the useful lives should be modified. Factors that are considered, include, but are not limited to, a significant decrease in market value, an adverse change in the manner in which a long-lived asset is used or a deterioration in physical condition, an adverse change in legal factors or business climate, or a decline in current-period operating cash flows. In the event impairment in value occurs and a portion of the carrying amount of the real estate investments will not be recovered in part or in whole, a provision will be recorded to reduce the carrying basis of the real estate investments and related intangibles to their estimated fair value. The
estimated fair value of our real estate investments is determined by using customary industry standard methods that include discounted cash flow and/or direct capitalization analysis or estimated cash proceeds received upon the anticipated disposition of the asset from market comparables.
Acquisition expenses. Acquisition costs are costs we incur in pursuing and closing property acquisitions. These costs include legal, accounting, valuation, and other professional or consulting fees. We account for acquisition related costs as expenses in the period in which the costs are incurred and the services are received.
Change in fair value of derivatives, net. We have implemented Accounting Standards Codification (ASC) 815, Derivatives and Hedging (ASC 815), which establishes accounting and reporting standards requiring that all derivatives, including certain derivative instruments embedded in other contracts, be recorded as either an asset or liability measured at their fair value unless they qualify for a normal purchase or normal sales exception. When specific hedge accounting criteria are not met, ASC 815 requires that changes in a derivatives fair value be recognized currently in earnings. All of the changes in the fair market values of our derivative instruments are recorded in the combined statements of operations.
Interest expense. We recognize the interest expense we incur on our borrowings as interest expense. Additionally, we incur non-cash charges such as legal fees, commitment fees and arrangement fees that reflect costs incurred with arranging certain debt financings. We generally recognize these costs over the term of the respective debt instrument for which the costs were incurred.
Cash Flow
Cash flows from operating activities. Cash flows from operating activities are derived largely from net income by adjusting our revenues for those amounts not collected in cash during the period in which the revenue is recognized and for cash collected that was billed in prior periods or will be billed in future periods. Net income is further adjusted by adding back expenses charged in the period that is not paid for in cash during the same period. We expect to make our distributions based largely from cash provided by operations.
Cash flows from investing activities. Cash flows from investing activities consist of cash that is used during a period for making new investments and capital expenditures offset by cash provided from sales of real estate investments.
Cash flows from financing activities. Cash flows from financing activities consist of cash we receive from issuances of debt and equity financings. This cash provides the primary basis for investments in new properties and capital expenditures. While we may invest a portion of our cash from operations into new investments, as a result of the distribution requirements to maintain our REIT status, it is likely that additional debt or equity financings will finance the majority of our investment activity. Cash used in financing activities consists of repayment of debt and distributions paid to shareholders and OP unit holders.
Results of Operations
Overview
As described above, following the completion of the IPO and the formation transactions, our structure and operations differ from the historical structure and operations of the Ziegler Funds. For this and other reasons set forth in Managements Discussion and Analysis of Financial Condition and Results of Operations, we do not believe that the Predecessors historical results of operations are indicative of our future operating results.
Three months ended September 30, 2013 compared to the three months ended September 30, 2012
The Trust was organized on April 9, 2013 and commenced operations on July 24, 2013. The 2013 results in this section include the results from July 24, 2013 through September 30, 2013, combined with the results of our Predecessor from July 1, 2013, through July 23, 2013. Comparative results reflect only the results of the Predecessor.
The following table summarizes our historical results of operations and the historical operations of our Predecessor for the three months ended September 30, 2013 and 2012 (in thousands):
|
|
2013 |
|
2012 |
|
Change |
|
% |
| |||
Revenues |
|
|
|
|
|
|
|
|
| |||
Rental revenues |
|
$ |
2,920 |
|
$ |
2,359 |
|
$ |
561 |
|
23.8 |
|
Expense recoveries |
|
798 |
|
750 |
|
48 |
|
6.4 |
| |||
Other revenues |
|
(5 |
) |
2 |
|
(7 |
) |
NM |
| |||
Total revenues |
|
3,713 |
|
3,111 |
|
602 |
|
19.4 |
| |||
Expenses |
|
|
|
|
|
|
|
|
| |||
Management fees |
|
|
|
238 |
|
(238 |
) |
(100.0 |
) | |||
General and administrative |
|
1,285 |
|
104 |
|
1,181 |
|
1,135.6 |
| |||
Operating expenses |
|
1,130 |
|
1,110 |
|
20 |
|
1.8 |
| |||
Depreciation and amortization |
|
1,146 |
|
973 |
|
173 |
|
17.7 |
| |||
Loss on sale of property under development |
|
2 |
|
161 |
|
(159 |
) |
(98.8 |
) | |||
Acquisition expenses |
|
756 |
|
|
|
756 |
|
NM |
| |||
Total expenses |
|
4,319 |
|
2,586 |
|
1,733 |
|
67.0 |
| |||
Operating (loss)/income |
|
(606 |
) |
525 |
|
(1,131 |
) |
(215.4 |
) | |||
Interest expense |
|
826 |
|
1,203 |
|
(377 |
) |
(31.3 |
) | |||
Change in value of derivatives, net |
|
(16 |
) |
|
|
(16 |
) |
|
| |||
Loss from continuing operations |
|
(1,416 |
) |
(678 |
) |
(738 |
) |
108.9 |
| |||
Discontinued operations: |
|
|
|
|
|
|
|
|
| |||
Loss from operations on discontinued Operations |
|
|
|
(262 |
) |
262 |
|
(100.0 |
) | |||
Gain on sale of investment properties |
|
|
|
1,179 |
|
(1,179 |
) |
(100.0 |
) | |||
Income from discontinued operations |
|
|
|
917 |
|
(917 |
) |
(100.0 |
) | |||
Net (loss)/income |
|
$ |
(1,416 |
) |
$ |
239 |
|
$ |
(1,655 |
) |
(692.5 |
) |
NM = Not Meaningful
Revenues
Total revenues increased $0.6 million, or 19.4%, for the three months ended September 30, 2013 as compared to the Predecessors three months ended September 30, 2012. An analysis of selected revenues follows.
Rental revenues. Rental revenues increased $0.6 million, or 23.8%, from $2.4 million for the three months ended September 30, 2012 to $2.9 million for the three months ended September 30, 2013. The increase in rental revenues primarily resulted from two property acquisitions which closed on August 30, 2013 and September 18, 2013 and resulted in an additional $0.4 million in revenue for the three months ended September 2013. The remaining increase was the result of contract rent increases and new leases.
Expense recoveries. Expense recoveries were relatively unchanged for the three months ended September 30, 2012 and 2013.
Expenses
Total expenses increased by $1.7 million, or 67.0%, for the three months ended September 30, 2013 as compared to the Predecessors three months ended September 30, 2012. An analysis of selected expenses follows.
Management Fees. The Predecessor incurred $0.2 million of management fees in the three months ended September 30, 2012. We do not incur these management fees. No management fees were incurred by the Predecessor in the three months ended September 30, 2013.
General and administrative. General and administrative expenses increased $1.2 million or 1,135.6%, from $0.1 million during the three months ended September 30, 2012 to $1.3 million during the three months ended September 30, 2013. The increase was the result of our operating as a public company since completion of our IPO on July 24, 2013. The increases included salaries and benefits of $0.6 million (including non-cash share compensation of $0.2 million), professional fees of $0.3 million, office start-up costs of $0.2 million and other administrative costs of $0.1 million.
Operating expenses. Operating expenses were relatively unchanged for the three months ended September 30, 2012 and 2013.
Depreciation and amortization. Depreciation and amortization increased $0.2 million, or 17.7%, from $1.0 million during the three months ended September 30, 2012 to $1.2 million during the three months ended September 30, 2013. The increase in depreciation and amortization was primarily from two acquisitions which closed on August 30, 2013 and September 18, 2013 and resulted in an additional $0.2 million in depreciation and amortization for the three months ended September 30, 2013.
Loss on sale of property under development. We incurred a loss of $1,846 on the sale of a medical office building condominium unit at the Summerfield Square property during the three months ended September 30, 2013. Total proceeds of the sale were $0.5 million. During the three months ended September 30, 2012, the Predecessor incurred a loss of $0.2 million on the sale of a condominium unit at the Summerfield Square property. Total proceeds on the sale were $0.3 million. We have 2,000 square feet remaining in the Summerfield Square property.
Acquisition expenses. Acquisition expenses were $0.8 million for the three months ended September 30, 2013. The Predecessor did not incur any acquisition expenses in the three months ended September 30, 2012. During the 2013 period, we acquired $111.8 million of real estate following completion of our IPO on July 24, 2013.
Interest expense. Interest expense for the three months ended September 30, 2013 was $0.8 million compared to $1.2 million for the Predecessor for the three months ended September 30, 2012, representing a decrease of $0.4 million, or 31.3%. The decrease was primarily the result of the repayment of $36.9 million of mortgage notes payable in connection with the formation transactions using proceeds from our IPO.
The above changes resulted in an increase of net loss from continuing operations of $0.7 million from a net loss from continuing operations of $0.7 million for the Predecessor for the three months ended September 30, 2012, to a net loss from continuing operations of $1.4 million for the three months ended September 30, 2013.
Income from discontinued operations. There were no discontinued operations in the three months ended September 30, 2013. In 2012, the Predecessor recorded income from discontinued operations and recognized a gain on the sale of a property of $1.2 million.
Net (loss)/income. Net loss for the three months ended September 30, 2013 was $1.4 million compared to net income of the Predecessor of $0.2 million for the three months ended September 30, 2012, due to the reasons described above.
Nine months ended September 30, 2013 compared to nine months ended September 30, 2012
The Trust was organized on April 9, 2013 and commenced operations on July 24, 2013. The 2013 results disclosed in this section include the results of the Trust from July 24, 2013, through September 30, 2013, combined with the results of our Predecessor from January 1, 2013 through July 23, 2013. Comparative results reflect only the results of the Predecessor.
The following table summarizes our historical results of operations and the historical operations of our Predecessor for the nine months ended September 30, 2013 and 2012 (in thousands):
|
|
2013 |
|
2012 |
|
Change |
|
% |
| |||
Revenues |
|
|
|
|
|
|
|
|
| |||
Rental revenues |
|
$ |
7,952 |
|
$ |
7,396 |
|
$ |
556 |
|
7.5 |
|
Expense recoveries |
|
2,399 |
|
2,151 |
|
248 |
|
11.5 |
| |||
Other revenues |
|
|
|
7 |
|
(7 |
) |
100.0 |
| |||
Total revenues |
|
10,351 |
|
9,554 |
|
797 |
|
8.3 |
| |||
Expenses |
|
|
|
|
|
|
|
|
| |||
Management fees |
|
475 |
|
713 |
|
(238 |
) |
(33.4 |
) | |||
General and administrative |
|
1,507 |
|
292 |
|
1,215 |
|
416.1 |
| |||
Operating expenses |
|
3,578 |
|
3,460 |
|
118 |
|
3.4 |
| |||
Depreciation and amortization |
|
3,123 |
|
2,901 |
|
222 |
|
7.7 |
| |||
Loss on sale of property under development |
|
2 |
|
228 |
|
(226 |
) |
(99.1 |
) | |||
Acquisition expenses |
|
756 |
|
|
|
756 |
|
|
| |||
Total expenses |
|
9,441 |
|
7,594 |
|
1,847 |
|
24.3 |
| |||
Operating income |
|
910 |
|
1,960 |
|
(1,050 |
) |
(53.6 |
) | |||
Interest expense |
|
3,114 |
|
3,667 |
|
(553 |
) |
(15.1 |
) | |||
Change in value of derivatives, net |
|
(206 |
) |
(58 |
) |
(148 |
) |
255.2 |
| |||
Loss from continuing operations |
|
(1,998 |
) |
(1,649 |
) |
(349 |
) |
21.2 |
| |||
Discontinued operations: |
|
|
|
|
|
|
|
|
| |||
Loss from discontinued operations |
|
|
|
(199 |
) |
199 |
|
(100.0 |
) | |||
Gain on sale of discontinued investment properties |
|
|
|
1,519 |
|
(1,519 |
) |
(100.0 |
) | |||
Income from discontinued operations |
|
|
|
1,320 |
|
(1,320 |
) |
(100.0 |
) | |||
Net loss |
|
$ |
(1,998 |
) |
$ |
(329 |
) |
$ |
(1,669 |
) |
507.3 |
|
Revenues
Total revenues increased $0.8 million, or 8.3%, for the nine months ended September 30, 2013 as compared to the nine months ended September 30, 2012. An analysis of selected revenues follows.
Rental revenues. Rental revenues increased $0.6 million, or 7.5%, from $7.4 million to $8.0 million. The increase in rental revenue primarily resulted from two property acquisitions which closed on August 30, 2013 and September 18, 2013, and resulted in an additional $0.4 million of revenue in the nine months ended September 30, 2013.
Expense recoveries. Expense recoveries increased $0.2 million, or 11.5%, from $2.2 million for the nine months ended September 30, 2012 to $2.4 million for the nine months ended September 30, 2013 due primarily to an increase in property related expenses which are reimbursed to us by tenants under our triple net leases.
Expenses
Total expenses increased $1.8 million, or 24.3% for the nine months ended September 30, 2013 as compared to the nine months ended September 30, 2012. An analysis of selected expenses follows.
Management Fees. The Predecessor incurred $0.5 million of management fees in the nine months ended September 30, 2013, compared to $0.7 million of management fees incurred by the Predecessor through July 23, 2013 in the nine months ended September 30, 2013. We do not incur these management fees.
General and administrative. General and administrative expenses increased $1.2 million, or 416.1%, from $0.3 million for the Predecessor during the nine months ended September 30, 2012 to $1.5 million during the nine months ended September 30, 2013. The increase in expenses is the result of Physicians Realty Trust operating as a public company since July 24, 2013. The increases included salaries and benefits of $0.6 million (including non-cash share compensation of $0.2 million), professional fees of $0.3 million, office start-up costs of $0.2 million and other administrative costs of $0.1 million.
Operating expenses. Operating expenses increased $0.1 million, or 3.4%, from $3.5 million for the Predecessor for the nine months ended September 30, 2012 to $3.6 million for the nine months ended September 30, 2013, due primarily to increases in real estate taxes of $0.1 million.
Depreciation and amortization. Depreciation and amortization increased $0.2 million, or 7.7%, from $2.9 million during the nine months ended September 30, 2012 to $3.1 million during the nine months ended September 30, 2013. The increase in depreciation and amortization resulted primarily from two property acquisitions which closed on August 30, 2013 and September 18, 2013 and resulted in an additional $0.2 million in depreciation and amortization for the nine months ended September 30, 2013.
Loss on sale of property under development. In September 2013, a loss on sale of $1,826 was recognized in connection with the sale of a condominium unit at the Summerfield Square property. In July 2012, a loss on sale of $0.2 million was recognized by the Predecessor in connection with the sale of a condominium unit at the Summerfield Square property.
Acquisition expenses. Acquisition expenses were $0.8 million for the nine months ended September 30, 2013. The Predecessor did not incur any acquisition expenses in the nine months ended September 30, 2012. During the 2013 period, we acquired $111.8 million of properties following completion of our IPO on July 24, 2013.
Interest expense. Interest expense for the nine months ended September 30, 2013 was $3.1 million compared to $3.7 million for the Predecessor for the nine months ended September 30, 2012, representing a decrease of $0.6 million, or 15.1%. The decrease was primarily due to the repayment of $36.9 million of mortgage notes payable in connection with the formation transactions using proceeds from our IPO.
Income from discontinued operations. There were no discontinued operations in the nine months ended September 30, 2013. In the nine months ended September 30, 2013, the Predecessor sold two properties located in Georgia and recognized a gain of $1.5 million.
Net loss. Net loss for the nine months ended September 30, 2013 was $2.0 million compared to a net loss of $0.3 million for the Predecessor for the nine months ended September 30, 2013, due to the reasons described above.
Cash Flows
Nine months ended September 30, 2013 compared to nine months ended September 30, 2012 (In thousands):
|
|
2013 |
|
2012 |
| ||
Cash (used in)/provided by operating activities |
|
$ |
(197 |
) |
$ |
2,424 |
|
Cash (used in)/provided by investing activities |
|
(101,179 |
) |
13,877 |
| ||
Cash provided by/(used in) financing activities |
|
102,995 |
|
(13,630 |
) | ||
Increase in cash and cash equivalents |
|
$ |
1,619 |
|
$ |
2,671 |
|
Cash flows from operating activities. Cash flows (used in)/provided by operating activities was $0.2 million during the nine months ended September 30, 2013 compared to cash flow provided by operating activities of the Predecessor of $2.4 million during the nine months ended September 30, 2012, representing a decrease of $2.6 million. This change was primarily attributable to a $1.7 million decrease in net income, a $1.7 million decrease in related party accounts payable and a $0.5 million increase in other assets, partially offset by a $0.8 million increase in accrued expenses.
Cash flows from investing activities. Cash flows used in investing activities was $101.2 million during the nine months ended September 30, 2013 compared to cash flow provided by investing activities of the Predecessor of $13.9 million during the nine months ended September 30, 2012, representing a change of $115.1 million. The increase in cash flows used in investing activities was primarily attributable to the acquisition of five properties for $100.1 million following the IPO and a $14.0 million decrease in proceeds from the Predecessors sale of property in the 2012 period.
Cash flows from financing activities. Cash flows provided by financing activities was $103.0 million during the nine months ended September 30, 2013 compared to cash flows used in financing activities for the Predecessor of $13.6 million during the nine months ended September 30, 2012, representing an increase of $116.6 million. The increase was primarily attributable to $135.2 million in proceeds from our IPO, proceeds of $19.9 million from credit facility borrowings, partially offset by $25.3 million in increased debt repayments, and $12.3 million in IPO costs.
Liquidity and Capital Resources
Our short-term liquidity requirements consist primarily of operating and interest expenses and other expenditures directly associated with our properties, including:
· property expenses,
· interest expense and scheduled principal payments on outstanding indebtedness,
· general and administrative expenses, and
· capital expenditures for tenant improvements and leasing commissions.
In addition, we will require funds for future distributions expected to be paid to our common shareholders and OP Unit holders in our Operating Partnership.
We expect to satisfy our short-term liquidity requirements through our existing cash and cash equivalents, cash flow from operating activities and borrowings available under our senior secured revolving credit facility.
Our long-term liquidity needs consist primarily of funds necessary to pay for acquisitions, recurring and non-recurring capital expenditures and scheduled debt maturities. We expect to satisfy our long-term liquidity needs through cash flow from operations, long-term secured and unsecured borrowings, issuances of equity securities, and, in connection with acquisitions of additional properties, the issuance of OP Units of our Operating Partnership, and proceeds from select property dispositions and joint venture transactions.
We intend to invest in additional properties as suitable opportunities arise and adequate sources of financing are available. We currently are evaluating additional potential investments consistent with the normal course of our business. There can be no assurance as to whether or when any portion of these investments will be completed. Our ability to complete investments is subject to a number of risks and variables, including our ability to negotiate mutually agreeable terms with sellers and our ability to finance the investment. We may not be successful in identifying and consummating suitable acquisitions or investment opportunities, which may impede our growth and negatively affect our results of operations and may result in the use of a significant amount of management resources. We expect that future investments in properties will depend on and will be financed by, in whole or in part, our existing cash, borrowings, including under our senior secured revolving credit facility or the proceeds from additional issuances of common or preferred shares, issuances of OP Units or other securities.
On August 29, 2013, we entered into a $75.0 million senior secured revolving credit facility. Subject to the satisfaction of certain conditions, including additional lender commitments, we have the option to increase the borrowing capacity under the revolving credit facility up to $250.0 million. The revolving credit facility has a three-year term with an initial maturity date of August 29, 2016. We have the option to extend the term to August 29, 2017. Borrowings under the senior secured revolving credit facility bear interest at rates generally between LIBOR plus 2.65% and LIBOR plus 3.40%. Any additional indebtedness incurred or issued by us may be secured or unsecured, may have a short, medium, or long term fixed or variable interest rate and may be subject to other terms and conditions. We may also enter into financing arrangements on terms that we might not otherwise accept if we were in need of liquidity and had limited options.
We currently do not expect to sell any of our properties to meet our liquidity needs, although we may do so in the future.
We intend to refinance at maturity the mortgage notes payable that have balloon payments at maturity.
We currently are in compliance with all debt covenants in our outstanding indebtedness.
Critical Accounting Policies
Our condensed, consolidated and combined financial statements are prepared in conformity with accounting policies generally accepted in the United States of America (GAAP), which require us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the combined financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. Set forth below is a summary of our accounting policies that we believe are critical to the preparation of our condensed, consolidated and combined financial statements.
Principles of Consolidation and Combination
Concurrently with the completion of the IPO, we entered into a series of contribution transactions with the Zeigler Funds acquiring 19 properties that comprise our initial properties, as well as certain operating assets and liabilities.
We did not conduct business operations prior to completion of the IPO on July 24, 2013, so the financial information herein for periods prior to July 24, 2013 reflects the operations of the Ziegler Funds, from whom we acquired the equity interests in the 19 properties that constituted our initial portfolio upon completion of the IPO and formation transactions. We determined the Ziegler Funds to be our accounting Predecessor. The financial information herein since July 24, 2013 reflect the operations of Physicians Realty Trust since completion of the IPO and formation transactions and includes the results of operations of the five acquisition properties described above from the date of our acquisition.
Our Predecessor, which is not a legal entity, is comprised of the four Ziegler Funds that owned directly or indirectly interests in entities that owned our initial 19 properties. Upon completion of the IPO and formation transactions, we acquired the interests in these entities from the Ziegler Funds. The combined historical data for our Predecessor is not indicative of our financial position or results of operations.
The accompanying condensed, consolidated and combined financial statements include the accounts of all controlled subsidiaries and joint ventures. The portion of the net income or loss attributed to third parties is reported as net income allocable to noncontrolling interests on the condensed, consolidated and combined statements of operations, and such parties portion of the net equity in such subsidiaries is reported on the condensed, consolidated and combined balance sheets as noncontrolling interests. All significant intercompany balances and transactions have been eliminated in consolidation and combination.
We consider ourselves to control an entity under Accounting Standards Codification (ASC) Topic 810 Consolidation (ASC 810), if we are the majority owner of and have voting control over such entity. We also assess control through means other than voting rights (variable interest entities or VIEs) and determine which business entity is the primary beneficiary of the VIE. A VIE is broadly defined as an entity where either the equity investors as a group, if any, do not have a controlling financial interest or the equity investment at risk is insufficient to finance that entitys activities without additional subordinated financial support. We consolidate VIEs when it is determined that we are the primary beneficiary of the VIE at either the date we became involved with the variable interest entity or upon the occurrence of a reconsideration event. We have concluded that one of our partially-owned entities (Summerfield Square) is a VIE.
Real Estate Investment Properties and Identified Intangible Assets
We are required to make subjective assessments of the useful lives of our properties for purposes of determining the amount of depreciation to record on an annual basis with respect to our investments in real estate. These assessments have a direct impact on our net income because if we were to shorten the expected useful lives of our investments in real estate we would depreciate such investments over fewer years, resulting in more depreciation expense and lower net income on an annual basis. Real estate investment properties and identified intangible assets are carried at cost, net of accumulated depreciation and amortization. Medical office buildings are depreciated over their estimated useful lives ranging up to 50 years using the straight-line method. Tenant improvements and in-place leases are amortized over the lease life of the in-place leases or the tenants respective lease term. Cost of maintenance and repairs are charged to expense when incurred.
We periodically assess the carrying value of real estate investments and related intangible assets in accordance with ASC 360, Property, Plant, and Equipment (ASC 360), to determine if facts and circumstances exist that would suggest that the recorded amount of an asset might be impaired or that the estimated useful live should be modified. In the event impairment in value occurs and a portion of the carrying amount of the real estate investment will not be recovered in part or in whole, a provision will be recorded to reduce the carrying basis of the real estate investment and related intangibles to their estimated fair value. The estimated fair value of our real estate investments is determined by use of a number of customary industry standard methods that include discounted cash flow modeling using appropriate discount and capitalization rates and/or estimated cash proceeds received upon the anticipated disposition of the asset from market comparables. Estimates of future cash flows is based on a number of factors including the historical operating results, leases in place, known trends, and other market or economic factors affecting the real estate investment. The evaluation of anticipated cash flows is subjective and is based on assumptions regarding future occupancy, lease rates and capital requirements that could differ materially from actual results. If our anticipated holding periods change or estimated cash flows decline based on market conditions or other unforeseen factors, impairment may be recognized. Long-lived assets to be disposed of are recorded at the lower of carrying value or fair value less costs to sell.
Revenue
We recognize rental revenues in accordance with ASC 840, Leases (ASC 840). ASC 840 requires that rental revenue, less lease inducements and above market leases, be recognized on a straight-line basis over the term of the lease when collectability is reasonably assured. Recognizing rental revenue on a straight-line basis for leases may result in recognizing revenue for amounts more or less than amounts currently due from tenants. Amounts recognized in excess of amounts currently due are included in other assets on the combined balance sheets. If we determine the collectability of straight-line rents is not reasonable assured, we limit future recognition to amounts contractually owed and, where appropriate, establish an allowance for estimated losses.
Expense recoveries related to tenant reimbursement for real estate taxes, insurance, and other operating expenses are recognized as expense recoveries revenue in the period the applicable expenses are incurred. The reimbursements are recognized at gross, as we are generally the primary obligor with respect to real estate taxes and purchasing goods and services from third-party suppliers, and have discretion in selecting the supplier, and bear the credit risk.
We have certain tenants with absolute net leases. Under these lease agreements, the tenant is responsible for operating and building expenses. For absolute net leases, the Trust does not recognize expense recoveries.
Lease Accounting
We, as lessor, make a determination with respect to each of our leases whether they should be accounted for as operating leases or direct financing leases. The classification criteria is based on estimates regarding the fair value of the leased facilities, minimum lease payments, effective cost of funds, the economic life of the facilities, the existence of a bargain purchase option, and certain other terms in the lease agreements. We believe all of our leases should be accounted for as operating leases. Payments received under operating leases are accounted for in the condensed, consolidated and combined statements of operations as rental revenue for actual rent collected plus or minus a straight-line adjustment for estimated minimum lease escalators, minus lease inducements, and minus above market leases. Assets subject to operating leases are reported as real estate investments in the condensed, consolidated and combined balance sheets.
Substantially all of our leases contain fixed or formula-based rent escalators. To the extent that the escalator increases are tied to a fixed index or rate, lease payments are accounted for on a straight-line basis over the life of the lease.
Derivative Instruments
We have implemented ASC 815, Accounting for Derivative Instruments and Hedging Activity (ASC 815), which establishes accounting and reporting standards requiring that all derivatives, including certain derivative instruments embedded in other contracts, be recorded as either an asset or liability measured at their fair value unless they qualify for a normal purchase or normal sales exception. We recognize our derivatives as a liability on the consolidated and combined balance sheets. When specific hedge accounting criteria is not met, ASC 815 requires that changes in a derivatives fair value be recognized currently in earnings. Changes in the fair market values of our derivative instruments are recorded in the condensed, consolidated and combined statements of operations. We did not designate our derivatives as a hedge.
Purchase of Investment Properties
Upon the acquisition of real estate properties, we estimate the fair value of acquired tangible assets (consisting of land, building, and improvements) and identified intangible assets and liabilities (consisting of above- and below-market leases, in place leases, and tenant relationships) based on the evaluation of information and estimates available at that date in accordance with the provisions of ASC 805, Business Combinations (ASC 805), and we allocate purchase price based on these assessments. We make estimates of the fair value of the tangible and intangible assets and acquired liabilities using information obtained from multiple sources as a result of pre-acquisition due diligence, which generally represents Level 3 inputs, and includes the assistance of a third party appraiser using the income approach method valuation. The income approach methodology utilizes the remaining noncancelable lease terms as defined in the lease agreements, market rental data, capitalization and discount rates. Based on these estimates, we recognize the acquired assets and liabilities at their estimated fair values. Initial valuations are subject to change until the information is finalized, no later than 12 months from the acquisition date. We expense transaction costs associated with ASC 805 in the period incurred. The fair value of tangible property assets acquired under ASC 805 considers the value of the property as if vacant determined by sales comparables and other relevant data. The fair value reflects the depreciated replacement cost of the permanent assets, with no trade fixtures included. The determination of fair value involves the use of significant judgment and estimation.
We determine the value of land either based on real estate tax assessed values in relation to the total value of the asset, internal analyses of recently acquired and existing comparable properties within our portfolio, or third party appraisals.
In recognizing identified intangible assets and liabilities of an acquired property, the value of above-or-below market leases is estimated based on the present value (using an interest rate which reflected the risks associated with the leases acquired) of the difference between contractual amounts to be received pursuant to the leases and managements estimate of market lease rates measured over a period equal to the estimated remaining term of the lease. The capitalized above-market or below-market lease intangibles are amortized as a reduction or addition to rental income over the estimated remaining term of the respective leases.
In determining the value of in-place leases and tenant relationships, management considers current market conditions and costs to execute similar leases in arriving at an estimate of the carrying costs during the expected lease-up period from vacant to existing occupancy. In estimating carrying costs, management includes real estate taxes, insurance, other operating expenses, estimates of lost rental revenue during the expected lease-up periods, and costs to execute similar leases, including leasing commissions, tenant improvements, legal, and other related costs based on current market demand. The values assigned to in-place leases and tenant relationships are amortized over the estimated remaining term of the lease. If a lease terminates prior to its scheduled expiration, all unamortized costs related to that lease are written off.
Use of Estimates
The preparation of the consolidated and combined financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated and combined financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates are made for the valuation of real estate and related intangibles, valuation of financial instruments, impairment assessments and fair value assessments with respect to purchase price allocations. Actual results could differ from those estimates.
Jumpstart Our Business Startups Act of 2012
The Jumpstart Our Business Startups Act of 2012, or JOBS Act, permits us, as an emerging growth company, to take advantage of an extended transition period to comply with new or revised accounting standards applicable to public companies. We have elected to opt out of this provision and, as a result, we will be required to comply with new or revised accounting standards as required when they are adopted. The decision to opt out of the extended transition period under the JOBS Act is irrevocable.
REIT Qualification Requirements
We are subject to a number of operational and organizational requirements necessary to qualify and maintain our qualification as a REIT. If we fail to qualify as a REIT or fail to remain qualified as a REIT in any taxable year, our income would be subject to federal income tax at regular corporate rates and potentially increased state and local taxes and could incur substantial tax liabilities which could have an adverse impact upon our results of operations, liquidity and distributions to our shareholders.
Real Estate Taxes
As owner of our properties, we are ultimately liable for the real estate taxes on our properties. Pursuant to our triple net lease agreements, tenants generally are responsible, directly or indirectly, for the payment of all real estate taxes assessed on our properties, which are subject to triple net leases.
Credit Facility
On August 29, 2013, we entered into a Credit Agreement with Regions Bank, as Administrative Agent, Regions Capital Markets, as Sole Lead Arranger and Sole Book Runner, and various other lenders in connection with a $75 million senior secured revolving credit facility (the Credit Agreement). Subject to satisfaction of certain conditions, including additional lender commitments, we have the option to increase the borrowing capacity under the revolving credit facility to up to $250 million. The amount available to us under the Credit Agreement is subject to certain limitations including, but not limited to, the appraised value of the pledged properties that comprise the borrowing base of the credit facility.
The Credit Agreement has a three-year term with an initial maturity date of August 29, 2016. Subject to the terms of the Credit Agreement, the Operating Partnership has the option to extend the term of the Credit Agreement to August 29, 2017.
We and certain subsidiaries guarantee the obligations of the Operating Partnership under the Credit Agreement. In addition, the Credit Agreement provides for security in the form of, among other things, mortgage liens on certain properties owned by the Operating Partnership that comprise the borrowing base.
The Credit Agreement provides for revolving credit loans to the Operating Partnership. Base Rate Loans, Adjusted LIBOR Rate Loans and Letters of Credit (each, as defined in the Credit Agreement) will be subject to interest rates, based upon the consolidated leverage ratio of us, the Operating Partnership and its subsidiaries as follows:
Consolidated Leverage Ratio |
|
Adjusted LIBOR Rate Loans and |
|
Base Rate Loans |
|
<35% |
|
LIBOR + 2.65% |
|
Base Rate + 1.65% |
|
>35% and <45% |
|
LIBOR + 2.85% |
|
Base Rate + 1.85% |
|
>45% and <50% |
|
LIBOR + 2.95% |
|
Base Rate + 1.95% |
|
>50% |
|
LIBOR + 3.40% |
|
Base Rate + 2.40% |
|
The Operating Partnership may, at any time, voluntarily prepay any loan under the Credit Agreement in whole or in part without premium or penalty.
The Credit Agreement contains financial covenants that, among other things, require compliance with loan-to-value, leverage and coverage ratios and maintenance of minimum tangible net worth, as well as covenants that may limit our and the Operating Partnerships ability to incur additional debt or make distributions. The Credit Agreement also contains customary events of default. Any event of default, if not cured or waived, could result in the acceleration of any outstanding indebtedness under the Credit Agreement.
Inflation
Historically, inflation has not had a significant impact on the operating performance of our properties. Many of our lease agreements contain provisions designed to mitigate the adverse impact of inflation. These provisions include clauses that enable us to receive payment of increased rent pursuant to escalation clauses which generally increase rental rates during the terms of the leases. These escalation clauses often provide for fixed rent increases or indexed escalations (based upon changes in the consumer price index or other measures). However, some of these contractual rent increases may be less than the actual rate of inflation. Most of our lease
agreements require the tenant to pay an allocable share of operating expenses, including common area maintenance costs, real estate taxes and insurance. This requirement reduces our exposure to increases in these costs and operating expenses resulting from inflation.
Seasonality
Our business has not been and we do not expect it to become subject to material seasonal fluctuations.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
Our future income, cash flows and fair values relevant to financial instruments are dependent upon prevailing market interest rates. Market risk refers to the risk of loss from adverse changes in market prices and interest rates. We use certain derivative financial instruments to manage, or hedge, interest rate risks related to our borrowings. We do not use derivatives for trading or speculative purposes and only enter into contracts with major financial institutions based upon their credit rating and other factors.
An interest rate swap is a contractual agreement entered into by two counterparties under which each agrees to make periodic payments to the other for an agreed period of time based on a notional amount of principal. Under the most common form of interest rate swap, known from our perspective as a floating-to-fixed interest rate swap, a series of floating, or variable, rate payments on a notional amount of principal is exchanged for a series of fixed interest rate payments on such notional amount.
No assurance can be given that any future hedging activities by us will have the desired beneficial effect on our results of operations or financial condition.
The variable rate component of our consolidated indebtedness at September 30, 2013 is LIBOR based. Assuming no increase in the amount of our variable rate debt, if LIBOR were to increase by 100 basis points, interest expense on our variable rate debt at September 30, 2013 would increase by approximately $0.3 million annually, and if LIBOR were to decrease by 100 basis points, interest expense on our variable rate debt at September 30, 2013 would decrease by approximately $0.3 million annually.
Interest risk amounts are our managements estimates and were determined by considering the effect of hypothetical interest rates on our consolidated financial instruments. These analyses do not consider the effect of any change in overall economic activity that could occur in that environment. Further, in the event of a change of that magnitude, we may take actions to further mitigate our exposure to the change. However, due to the uncertainty of the specific actions that would be taken and their possible effects, these analyses assume no changes in our financial structure.
Item 4. Controls and Procedures
We maintain disclosure controls and procedures (as such term is defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act) that are designed to ensure that information required to be disclosed in our reports under the Exchange Act is processed, recorded, summarized and reported within the time periods specified in the rules and regulations of the U.S. Securities and Exchange Commission (SEC) and that such information is accumulated and communicated to management, including our Chief Executive Officer and Principal Financial and Accounting Officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.
We have carried out an evaluation, under the supervision and with the participation of management, including our Chief Executive Officer and Principal Financial and Accounting Officer, regarding the effectiveness of our disclosure controls and procedures as of September 30, 2013, the end of the period covered by this report. Based on the foregoing, our Chief Executive Officer and Principal Financial and Accounting Officer have concluded, as of September 30, 2013, that our disclosure controls and procedures were effective in ensuring that information required to be disclosed by us in reports filed or submitted under the Exchange Act (i) is processed, recorded, summarized and reported within the time periods specified in the SECs rules and forms and (ii) is accumulated and communicated to our management, including our Chief Executive Officer and our Principal Financial and Accounting Officer, as appropriate to allow for timely decisions regarding required disclosure.
No changes to our internal control over financial reporting were identified in connection with the evaluation referenced above that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
From time to time, we are party to various lawsuits, claims and other legal proceedings that arise in the ordinary course of our business. We are not currently a party, as plaintiff or defendant, to any legal proceedings which, individually or in the aggregate, would be expected to have a material effect on our business, financial condition or results of operations if determined adversely to us.
There have been no material changes from the risk factors disclosed in the section entitled Risk Factors of our final prospectus.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
On July 24, 2013, in connection with the Formation Transactions, we issued to the Ziegler Funds an aggregate of 2,744,000 common units of limited partnership interest in our Operating Partnership (OP Units) with an aggregate value of approximately $31.6 million based on the IPO price on $11.50 per share for our common shares. The issuance of such units was effected in reliance upon exemptions from registration provided by Section 4(2) of the Securities Act and Regulation D of the Securities Act. Pursuant to the partnership agreement of our Operating Partnership, limited partners of our Operating Partnership will have the right, commencing one year from the date of issuance of such units, to require our Operating Partnership to redeem part or all of their OP Units for cash equal to the then-current market value of an equal number of our common shares, or, at our election, for common shares on a one-for-one basis, subject to certain adjustments and the restrictions on ownership and transfer of our shares set forth in our charter.
On July 24, 2013, we closed the IPO, pursuant to which we sold 10,434,782 common shares to the public at a public offering price of $11.50 per share. We raised approximately $120 million in gross proceeds, resulting in net proceeds to us of approximately $109.8 million after deducting approximately $8.4 million in underwriting discounts and approximately $1.8 million in other expenses relating to the IPO. On August 7, 2013, the underwriters of the IPO exercised their overallotment option to purchase an additional 1,318,815 common shares, resulting in additional net proceeds to us of approximately $14 million after deducting approximately $1.2 million in underwriting discounts.
All of the 11,753,597 shares were sold in the IPO pursuant to (i) our registration statement on Form S-11, as amended (File No. 333-188862), that was declared effective by the SEC on July 18, 2013 and (ii) our immediately effective registration statement on Form S-11 (File No. 333-190022) filed with the SEC on July 19, 2013 pursuant to Rule 462(b) of the Securities Act. Wunderlich Securities, Inc., Oppenheimer & Co. Inc., Janney Montgomery Scott LLC, JMP Securities LLC, BB&T Capital Markets, a division of BB&T Securities, LLC served as joint book-running managers for the offering and Compass Point Research & Trading LLC, J.J.B. Hilliard, W.L. Lyons, LLC and B.C. Ziegler and Company served as co-managers for the offering.
We contributed the net proceeds of the IPO to our Operating Partnership in exchange for OP Units, and our Operating Partnership used the net proceeds received from us as described below:
· approximately $36.9 million to repay outstanding indebtedness, including accrued interest;
· approximately $900,000 to pay certain debt transfer fees and fees relating to our senior secured revolving credit facility; and
· approximately $850,000 to purchase the remaining 50.0% joint venture equity interest in the Arrowhead Commons property not owned by the Ziegler Funds
No payments were made by us to trustees, officers or persons owning ten percent or more of our common shares or to their associates, or to our affiliates, other than payments in the ordinary course of business to officers for salaries. We deposited the funds received in U.S. Bank NA.
Since completion of the IPO, we have applied the net proceeds of the IPO to the acquisition of the following properties:
Property |
|
Location |
|
Acquisition |
|
Square |
|
Purchase |
| |
Hospital |
|
El Paso, TX |
|
August 30, 2013 |
|
77,000 |
|
$ |
32,823,775 |
|
Medical Office Building |
|
El Paso, TX |
|
August 30, 2013 |
|
40,000 |
|
$ |
7,176,225 |
|
Long Term Acute Care Specialty Hospital |
|
Plano, TX |
|
September 18, 2013 |
|
75,442 |
|
$ |
18,200,000 |
|
Hospital |
|
New Orleans, LA |
|
September 30, 2013 |
|
60,000 |
|
$ |
37,500,000 |
|
Outpatient Care Building |
|
Oklahoma City, OK |
|
September 30, 2013 |
|
52,000 |
|
$ |
15,600,000 |
|
This use of proceeds does not represent a material change from the use of proceeds described in the final prospectus.
As partial payment of the purchase price for the hospital, in New Orleans, Louisiana described above, on September 30, 2013, we issued an aggregate of 954,877 OP Units valued at $11.5 million on the date of issuance based on a three-day average closing price of our common shares prior to closing the acquisition to the sellers of that property. The issuance of such OP Units was exempt from registration pursuant to Section 4(2), thereof, for transactions not involving public offering.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not Applicable
Not Applicable
Exhibit No. |
|
Description |
10.1(1) |
|
Form of Amended and Restated Agreement of Limited Partnership of Physicians Realty L.P. |
10.2(1) |
|
Form of Physicians Realty Trust 2013 Equity Incentive Plan |
10.3(1) |
|
Form of Restricted Shares Award Agreement (Time Vesting) |
10.4(1) |
|
Form of Indemnification Agreement between Physicians Realty Trust and its trustees and officers |
10.5(1) |
|
Contribution Agreement by and among Physicians Realty L.P., Physicians Realty Trust and Ziegler Healthcare Real Estate Fund I, dated as of June 19, 2013 |
10.6(1) |
|
Contribution Agreement by and among Physicians Realty L.P., Physicians Realty Trust and Ziegler Healthcare Real Estate Fund II, dated as of June 19, 2013 |
10.7(1) |
|
Contribution Agreement by and among Physicians Realty L.P., Physicians Realty Trust and Ziegler Healthcare Real Estate Fund III, dated as of June 19, 2013 |
10.8(1) |
|
Contribution Agreement by and among Physicians Realty L.P., Physicians Realty Trust and Ziegler Healthcare Real Estate Fund IV, LP, dated as of June 19, 2013 |
10.9(1) |
|
Form of Shared Services Agreement by and among Physicians Realty Trust, Physicians Realty L.P. and B.C. Ziegler and Company |
10.10(1) |
|
Membership Interest Purchase Agreement for the Arrowhead Commons property by and among Physicians Realty L.P., Birdie Zone, L.L.C., Ziegler Healthcare Real Estate Fund I and Ziegler-Arizona 23, LLC dated as of June 24, 2013 |
10.11(1) |
|
Form of Employment Agreement by and between Physicians Realty Trust and John T. Thomas |
10.12(1) |
|
Form of Employment Agreement by and between Physicians Realty Trust and Mark D. Theine |
10.13(1) |
|
Form of Employment Agreement by and between Physicians Realty Trust and John W. Sweet Jr. |
10.14(1) |
|
Form of Employment Agreement by and between Physicians Realty Trust and John W. Lucey |
10.15(2) |
|
Credit Agreement, dated as of August 29, 2013, among Physician Realty L.P. as Borrower, Physicians Realty Trust, certain Subsidiaries and other Affiliates of the Borrower party, as Guarantor, Regions Bank, as Administrative Agent, Regions Capital Markets, as sole Lead Arranger and Sole Book Runner, and the Lenders party thereto |
10.16(2) |
|
Agreement of Sale and Purchase, by and between Physicians Realty L.P., a Delaware Limited Partnership, and 6800 Preston Limited, a Texas Limited Partnership, dated August 21, 2013 |
10.17 |
|
Assignment and Assumption of Agreement of Sale and Purchase by and between Foundation Surgical Hospital Affiliates, L.L.C., a Nevada limited liability company, and doc-fsh el paso medical center, llc, a Wisconsin limited liability company on August 30, 2013. |
10.18 |
|
Agreement of Sale and Purchase by and between hcri texas properties, ltd., a Texas limited partnership, health care reit, inc., a Delaware corporation (HCN), and foundation surgical hospital affiliates, L.L.C., a Nevada limited liability company, as of August 30, 2013 |
10.19 |
|
Membership Interest Contribution Agreement by and among doc-ccsc Crescent City Surgical Centre, LLC, Crescent City Surgical Centre Facility, LLC, Physicians Realty L.P. and the Members of Crescent City Surgical Centre Facility, LLC dated as of September 30, 2013 |
31.1* |
|
Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
31.2* |
|
Certification of Principal Financial and Accounting Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
32.1** |
|
Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
Exhibit No. |
|
Description |
32.2** |
Certification of Principal Financial and Accounting Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
|
| |
101.INS** |
XBRL Instance Document(+) | |
|
| |
101.SCH** |
XBRL Extension Schema Document(+) | |
|
| |
101.CAL** |
XBRL Taxonomy Extension Calculation Linkbase Document(+) | |
|
| |
101.DEF** |
XBRL Taxonomy Extension Definition Linkbase Document(+) | |
|
| |
101.LAB** |
XBRL Taxonomy Extension Label Linkbase Document(+) | |
|
| |
101.PRE** |
XBRL Taxonomy Extension Presentation Linkbase Document(+) |
(1) Incorporated herein by reference to Physician Realty Trusts Registration Statement on Form S-11, as amended (File No. 333-188862), originally filed with the Securities and Exchange Commission on May 24, 2013
(2) Incorporated herein by reference to Physicians Realty Trusts Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 30, 2013 (File No. 001-36007)
* Filed herewith
** Furnished herewith
(+) Users of this data are advised pursuant to Rule 406T of Regulation S-T that this interactive data file is deemed not filed or part of a registration statement for purposes of Section 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
PHYSICIANS REALTY TRUST |
|
|
|
|
Date: November 12, 2013 |
/s/ John T. Thomas |
|
John T. Thomas |
|
Chief Executive Officer and President |
|
(Principal Executive Officer) |
|
|
|
|
Date: November 12, 2013 |
/s/ John W. Lucey |
|
John W. Lucey |
|
Senior Vice PresidentPrincipal Accounting and Reporting Officer |
|
(Principal Financial and Accounting Officer) |